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SPATIAL CONTRAST SENSITIVITY IN CLINICAL NEUROlOGY 
GENERAL INTRODUCTION 
The visual system is the most complex sensory system known to man. This 
is not surprising if one considers its enormous capacities, ranging from finding 
one's way to the appreciation of art. Fortunately, the system can be studied 
by many approaches and the results, in addition to elucidating the process 
of vision, advance the understanding of brain function in general. 
This thesis is devoted to one new diagnostic technique called spatial contrast 
sensitivity (CS) measurement, to study visual function. This technique provides 
a much more comprehensive measure of visual efficiency than a standard acuity 
score. The visibility of objects depends not only on their size, but also on 
their relative brightness with respect to the background. Spatial contrast sensitivity 
measurement takes into account the contrast necessary for an object of any 
size to be detected. For its proper application in clinical neuro-ophthalmology, 
knowledge about the principles underlying human spatial contrast sensitivity 
is required. 
Chapter I reviews the neurophysiological concepts underlying human contrast 
sensitivity (part 1). Based on results of both electrophysiological studies of single 
cells in animals and psychophysical investigations of the human visual system, 
many investigators have proposed that there might be parallel pathways in 
the visual system, selectively responding to different spatial frequencies. It will 
be shown why spatial contrast sensitivity is not predictable from visual acuity. 
The equipment and procedures necessary for performing clinical contrast 
sensitivity measurement are described in part 2. The results of contrast sensitivity 
measurement in 54 control subjects with normal visual acuity, the influence 
of age and intrasubject variability are discussed in part 3. 
Following the description of the normal contrast sensitivity curve, the effects 
of various neurological disorders involving the visual pathway are discussed: 
Parkinson's disease, drug-induced Parkinsonism, cerebral infarctions, cerebral 
tumours and Benign intracranial hypertension. 
Parkinson's disease is a generalized dopaminergic deficiency syndrome. The 
visual system functions in part by dopaminergic mechanisms. In view of this 
contrast sensitivity function was investigated in patients with Parkinson's disease. 
In Chapter II, part 1, the results of contrast sensitivity measurement in 39 
patients with Parkinson's disease are described. 
It was hypothesized that if dopamine is a functional transmitter in the visual 
system, levodopa treatment will change contrast sensitivity function in patients 
with Parkinson's disease. The effect of this therapy on contrast sensitivity is 
described in part 2. 
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An intriguing question concerns the site of involvement in the visual system 
to explain contrast sensitivity abnormalities in Parkinson's disease. It has been 
demonstrated in animal studies that orientation-selective neurons are almost 
,exclusively located at a cortical leveL Since dysfunction of the visual cortex 
may play a role in shaping contrast sensitivity loss, we were curious whether 
orientation-specific losses could be demonstrated in Parkinson's disease. The-
refore, the effect of stimulus orientation on contrast sensitivity in 21 patients 
with Parkinson's disease was investigated. The results of this part of the study 
are described in part 3. 
Drug-induced Parkinsonism is a generalized condition that resembles 
Parkinson's disease clinically and biochemically. If it can be assumed that there 
is a dependence of contrast sensitivity function on the dopaminergic system, 
systemic administration of dopamine antagonists will affect contrast sensitivity 
in a similar way as in idiopathic Parkinson's disease. This hypothesis was tested 
by comparing contrast sensitivity function in both conditions (part 4). 
The assumed existence of parallel spatial frequency channels in the human 
visual system brings up the possibility that anatomical lesions of the visual 
pathway might selectively damage some frequency-selective channels, while the 
others continue to function normally. Such lesions might implicate central visual 
funtion, without affecting visual acuity. Contrast sensitivity examination might 
designate which part of the spatial frequency range is affected by different 
lesions comprising the posterior visual pathway. In Chapter III contrast sensitivity 
function in 16 patients with unilateral ischaemic lesions involving the posterior 
visual pathway are documented. 
Patients with cerebral tumours may exhibit a variety of visual symptoms and 
signs each of which relates to an important aspect of the underlying patho-
physiology. Tumours involving the visual pathway itself usually account for 
visual acuity impairment or field defects. Tumours without direct effect on the 
visual pathway, but interfering with CSF flow (papilloedema, hydrocephalus), 
can also exhibit visual damage. In Chapter IV the results of a study of contrast 
sensitivity function in 23 patients with cerebral tumours causing visual distur-
bances by diverse mechanisms are discussed. 
Finally, the clinical application of contrast sensitivity measurement in Benign 
Intracranial Hypertension (BIH) was investigated in 20 patients. BIH is a 
syndrome with raised CSF pressure not due to a space-occupying lesion, and 
with a normal CSF and ventricular system. Loss of visual acuity is the only 
serious complication, and may occur either early or late in its course. Progression 
or regression of the disease can be monitored as is illustrated by serial 
measurements in 11 patients (Chapter V). 
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Chapter I 
CONTRAST SENSITIVITY IN CLINICAL NEUROlOGY 
Part 1: Neurophysiological concepts underlying human contrast sensitivity 
Many neurological disorders are accompanied by visual disturbances, which 
can be studied by various approaches. In clinical practice, visual acuity 
estimations and charting of the visual fields are the two most generally accepted 
measures of visual function. A test for visual acuity by means of the Snellen 
chart describes the ability to resolve fine spatial detail. The letters used are 
highly contrasted with their background. In this method of assessing visual 
function, assumptions are made about the visual competence and the stimulus 
used. One is that the capacity to resolve the smallest detectable letters will 
describe the capacity of the visual system to resolve objects of all size. Another 
implicit assumption is that contrast is not of primary importance in assessing 
visual competence. However, the capacity of the visual system to resolve larger 
objects of different levels of contrast is also of great importance. Patients with 
visual acuities of 10/10 or more may complain of visual disturbances in seeing 
large objects blurred or 'misty'. Such visual loss is not shown by Snellen's test. 
The visibility of objects does not only depend on their size, but also on their 
relative brightness with respect to the background. 
Spatial contrast sensitivity (CS) measurements take into account the contrast 
necessary for an object of any size to be detected. Over the last 15 years it 
has become clear that CS measurements can give information about visual 
function not obtainable by other methods. Campbell and Green (1965) first 
measured visual CS using sinusoidal grating patterns. The term "grating" 
indicates that the pattern is composed of regularly alternating light and dark 
bars. The grating usually employed in visual studies is sinusoidal, where the 
luminance of the dark and light bars are varied in sinusoidal fashion. The 
mean luminance of the grating is kept constant while the contrast is varied. 
The contrast threshold of a person is defined as the minimum of contrast 
required to distinguish a grating pattern rather than a uniform screen. The 
contrast of the grating pattern was defined as C = (Lmax- Lmin)/(Lmax + Lmin), 
where Lmax and Lmin are the maximum and minimum luminance, respectively. 
The CS has been defined as the reciprocal value of the threshold contrast. 
The spatial frequency of a grating represents the number of cycles (dark-light 
pairs) of the sinusoid per unit distance, measured in degrees of visual angle. 
A plot of the CS over a range of spatial frequencies is called the CS curve. 
Such a curve shows a person's ability to detect fine and coarse targets, the 
capacity for visual discrimination of everyday objects. The physiological im-
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portance of CS measured with sinusoidal gratings is related to concepts 
concerning system analysis. Any visual image can be considered as a combination 
of many spatial frequencies at multiple orientations in two or three dimensions. 
Any such stimulus can be constructed by superimposing sinusoidal gratings 
of different spatial frequencies, contrasts, and phases (positions). The amount 
and phase of each spatial frequency contained in a stimulus are given by the 
Fourier transform of the stimulus obtained through the process of Fourier 
analysis. 
Electrophysiological studies in animals have demonstrated that single neurons 
in the visual pathway are 'tuned' to respond to a restricted range of spatial 
frequencies. The band of frequencies narrows from retina to the striate cortex 
where 'simple cells' have the narrowest band or 'sharpest' tuning (Maffei et 
al., 1973). Psychophysical investigations of the human visual system have similarly 
shown that the sensitivity of the visual system to the detection of contrast varies 
according to the spatial frequency, over a range of approximately 0.1 to 60 
cycles per degree of visual arc (Campbell, 1977; Campbell & Maffei, 1974; Watson 
et al., 1983). The highest contrast sensitivity is in the range of two to three 
cycles per degree. 
Considering these single-unit and psychophysical findings, many investigators 
have proposed that visual information is transmitted via multiple channels, 
each channel carrying a limited range of spatial frequencies, or other aspects, 
of a visual image (Campbell & Robson, 1968; Regan, 1982). The channel 
hypothesis holds that aspects of the visual image are 'filtered' as they enter 
the retina (e.g. by a center-surround receptive field, by colour-selective cone 
receptors or by a cell 'tuned' to specific spatial frequencies), and are transmitted 
via parallel channels, more or less independent of one another (Regan, 1982). 
Visual disturbances can result from damage to some or all spatial frequency 
channels. Such abnormal visual function does not necessarily result in abnormal 
Snellen acuity. This can be applied i:o. clinical neurology. 
Part 2. Methods of measurement of contrast sensitivity 
Apparatus 
CS functions were obtained by means of sine wave gratings displayed on 
a video monitor (Bosch, type M 38 BA 487 TA). The gratings were generated 
conventionally (Campbell & Robson, 1968; Keemink et al., 1979) and controlled 
by a micro-processor. 
Contrast was measured to be linear up t61 00 per cent for all spatial frequencies 
used. The mean luminance for all stimuli presented was 5 cd/m2• To avoid 
afterimages, the phase of the grating was alternated with a frequency of 0.8 Hz. 
The light and dark bars changed places periodically, so that each part of the 
retina was light adapted to the same extent It is known that, in measurements 
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using gratings consisting of less than four or five cycles, the CS is strongly 
dependent on the number of cycles presented (Savoy & McCann, 1975; Van 
der Wildt et al., 1976). To realize that all gratings presented, consisted of four 
or more cycles, it was not possible to measure CS for all spatial frequencies 
at one viewing distance. Therefore the monitor was placed at a distance of 
50 em from the eye of the subject for spatial frequencies of 0.1 to 0.8 cycles/ 
degree. For higher spatial frequencies (0.8 to 25.6 cycles/degree) the distance 
from the eye was automatically changed into 200 em to compensate for limitations 
in the monitor system at high frequencies. 
The stimulus field for vertical gratings subtended a visual angle of 32.5° 
horizontally and 23.SO vertically at 50 em and 8.5° and 6.0° respectively, at 200 
em. For horizontal gratings the monitor was simply rotated. The visual angle 
of the stimulus field was 23.5° horizontally and 32.5° vertically at 50 em and 
6° and 8.5°, respectively, at 200 em. The stimulus field was viewed in a dark 
surrounding. Each eye was tested separately. 
Test procedure 
The measuring technique was based on a modified version of the Von Bekesy 
tracking method (Von Bekesy, 1947). This procedure was conducted under 
computer control. The subject reduced the contrast of the grating by depressing 
a push button. As soon as the contrast was subthreshold, the button had to 
be released, which caused the contrast to increase. When the grating became 
just visible the subject depressed the button again. Repeating this procedure, 
the contrast of the grating varied around the subject's threshold. The higher 
and lower contrast-reversal values were averaged, and this value was taken 
as the subject's threshold for that spatial frequency. To avoid adaptation effects, 
the first four reversal values were not used. The computer ignored the two 
highest and the two lowest values and stored the remaining eight consecutive 
reversal points. Contrast sensitivity was taken to be the reciprocal of the mean 
of the eight stored contrast values. Contrast sensitivity was plotted as a function 
of spatial frequency by a microprocessor on a X-Y plotter. The CS was recorded 
over a spatial frequency range from 0.1 to 25.6 cycles/degree. Fig. 1 shows 
examples of sinusoidal gratings at one spatial frequency but of different contrasts. 
The measuring procedure started at the lowest frequency. When the CS at 
this frequency was plotted, the next frequency, twice the first, was automatically 
presented on the screen, and so on, until CS at all the preselected spatial 
frequencies had been measured. Optional was the possibility to measure a 
number of specified spatial frequencies with a minimum mutual difference 
to a factor J2. This could be used when a particular pan of the spatial frequency 
range was of interest. The method made it possible to determine a complete 
CS function for both eyes in about 20 minutes. 
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Figure l. Two examples of sinusoidal grating patterns of one spatial frequency and equal mean 
luminance. The pattern at the top is higher in contrast than the one at the bottom. 
Part 3. Contrast sensitivity in normal subjcets 
Introduction 
It is generally accepted that the efficiency of the visual system declines with 
aging. For many of the visual and ocular motor subsystems, data are available 
to define normal according to the patient's age. For others it is not (Weale, 
1975). Visual acuity is probably the most studied visual parameter in aging 
(Anderson & Palmore, 1974; Richards, 1977). A modest decline in visual acuity 
prior to age 60 has been documented, followed by a rapid decline, in many 
patients, from 60 to 80 years of age. One of the problems with acuity testing 
is that most chart systems do not have sufficient gradations to test vision better 
than 10/10, a Snellen acuity that is actually at the lower limit of 'normal'. 
Feisen and Frisen (1979) found that 10/10 vision requires no more than 44% 
functional acuity channels. 
Contrast Sensitivity measurement is an additional means of analyzing central 
vision. Ginsburg (1981) demonstrated that threshold detection and identification 
of letters of various sizes are directly related to a subject's CS, not his visual 
acuity. CS measurement is a subjective test, and may be affected by several 
factors, such as the compliance of the subject to guess or wait until certain 
before responding, the rate of exposure of the grating pattem to the subject, 
and so on. These factors will cause a substantial intersubject variability without 
affecting the shape of the curve. For the investigation of CS function in 
pathological conditions, it is necessary to establish 'normal values' and analyze 
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the effect of age to differentiate the effects of the normal ageing process from 
visual pathology. A fundamental assumption implicit in valid diagnosis and 
monitoring the CS in the individual patient is a subject's test and retest 
consistency. In this study CS was measured in a normal population, comparing 
several age-groups. In addition the intrasubject variability was examined in 
five subjects. 
Subjects 
The group of 54 normal subjects consisted of hospital personnel and patients 
without CNS disease. All had ophthalmological examination and were free of 
ocular disease. Subjects with known astigmatism were excluded. Snellen acuities, 
measured with refractive correction where necessary, were 10/10 or better. 
Results 
The group of 54 normal subjects (108 eyes) was divided in five decades 
of age: 11 subjects were in their third decade, 15 in their fourth, nine in 
their fifth, ten in their sixth, and nine in their seventh decade. The mean 
age was 47 years (range, 21-70). There was no influence of age on the mean 
score (Fig. 2). The mean CS curve, based on all data (108 eyes) is shown in 
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14 
Fig. 3. Five subjects, one of each decade, were retested one to six months 
later. The mean magnitude of variability was only 1.4 (2 SD 0.3), which means 
a great test-retest consistency. 
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Figure 3. Mean contrast sensitivity curve of 108 normal eyes. 2 SD (---). 
Discussion 
The normal CS curve increased linearly in the low spatial frequency range, 
packed at the middle frequency area of 1.6 to 3.2 cycles/ degree and fell off 
exponentially at higher frequencies. CS varied within each age-decade subgroup 
(intersubject variability), but was not affected by age in this group of normal 
subjects. These results are in disagreement with previous reports. Skalka (1980) 
found advancing age to be associated with reduction of CS, irrespective of 
spatial frequency. This could not be confirmed by Sekuler and Hutman (1980) 
who found a reduction only at low spatial frequencies. In subsequent papers 
Sekuier and colleagues (Owsley 1982; Sekuler & Owsley, 1982) reported CS 
to be reduced at high spatial frequencies. Singh et al. (1981) found only very 
slight reduction of CS, only after the sixth decade. A major problem in the 
study of the results reported in the literature is that many different stimulation 
methods and conditions of investigation were used. The conflicting results 
mentioned above may be explained because some of these workers used grating 
booklets of Arden (Arden, 1978) to measure CS, which is a less accurate method. 
High spatial frequencies (above 6.4 cycles/degree) cannot be tested with this 
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method. Moreover, Skalka (1980) biased his results by repeating the test only 
if abnormal results were obtained. Schlotterer et al. (1983), who used methods 
similar to those described here, found that' old people' had high spatial frequency 
loss. In their study CS was determined at six different spatial frequencies, up 
to 12 cycles/degree. Visual acuities in their older group, however, were 
significantly poorer than in the younger group. It is not surprising to find 
high frequency loss in subjects with 'significant poorer visual acuities'. 
Age-related changes of the visual system are well known. Optical transmission 
is reduced, lenticular changes and senile miosis cause increased light scatter 
(Ruddock, 1965; Corso, 1971 ). Little is known, however, about changes in central 
visual processes with increasing age. Important aspects ofbrain functional activity 
are not reduced in the elderly (Creasey & Rapoport, 1985). CS function in 
this study of subjects with normal Snellen acuities was not affected by age. 
The intrasubject variability was measured in five subjects by retesting CS 
one to six months later. The mean magnitude of variability was only 1.4 (2 
SD 0.3). This great repeatability of a subject's CS function by the adjusted Von 
Bekeksy tracking method is in disagreement with the observations of Ginsburg 
and Cannon (1983) on CS measurements by this psychophysical method. A 
possible explanation of the variance might be that they did not control for 
the effects of afterimages by changing the spatial phase of the gratings 
periodically. Unusual CS values in the order of 1,000, as they found, were 
not measured in the subjects of this study. 
In obtaining CS function in neurological patients, it is important to be prepared 
to deal with a number of pitfalls. Neurological patients do not only distinct 
from normal subjects in having a specific disease, some additional features 
can alsq contribute to his or her test condition. Some patients are easily tired, 
which makes the measurements rather time consuming. 
In conclusion, CS function using stimulation methods and conditions of 
investigation as described above is not affected by aged. There is a great test-
retest consistency. 
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Chapter II 
CONTRAST SENSITIVITY IN PARKINSON'S DISEASE 
Part 1. Loss of contrast sensitivity in Parkinson's disease 
INTRODUCTION 
Although motor manifestations are the main sequelae of Parkinson's disease 
(Parkinson, 1817), the disorder is probably more generalized (Barbeau et al., 
1975), and due to a generalized dopaminergic deficiency. The retina and lateral 
geniculate body function in part by dopaminergic mechanisms (Haggendal 
& Malmfors, 1965; Deffenu et al., 1967; Phillis et al., 1967; Lindvall et al., 1973; 
Dyer et al., 1981). In view of the assumed dopaminergic transmission visual 
evoked potential (VEP) studies have been undertaken in Parkinson's disease 
(PD). Abnormal responses were seen by some investigators (Bodis-Wollner & 
Yahr, 1978; Mintz et al., 1981; Kupersmith et al., 1982; Bodis-Wollner et al., 
1982), but not by others (Delwaide et al., 1980; Ehle et al., 1982). Both abnormal 
and normal responses were found in the same PD patient depending on the 
stimulus used (Tartaglione et al., 1984). In this study contrast sensitivity (CS) 
measurements were used to analyse visual function in PD. 
SUBJECTS 
The control group of 25 subjects consisted of hospital personnel and patients 
without CNS disease. All had ophthalmological examination and were free of 
ocular disease. Subjects with known astigmatism were excluded. Snellen acuities 
were 10/10 or better. 
Thirty-nine patients with the diagnosis of PD, who had not been treated 
with levodopa, were examined. The severity of their disease was rated according 
to Hoehn and Yahr (1967). All but eight patients were treated with anticho-
linergics and/ or amantadine. The eight patients who had no therapy were 
all in stage I. The patients were also classified in three subgroups according 
to the main initial sign of disease (hypokinesia, tremor, or rigidity). All had 
ophthalmological examination, including corrected visual acuity measurement. 
Patients with known astigmatism were excluded. 
RESULTS 
Control group 
The mean age of the control group was 67 years (range, 53-80). The CS 
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functions of the 50 control eyes were obtained and the mean CS curve is shown 
in Fig. 4. Twenty-eight eyes (20 subjects) showed a slight decrease in CS at 
different spatial frequencies between 0.2 and 12.8 cycles/ degree. The decrease 
factor (DF) of these minor deflections was defined as the ratio of the measured 
CS and the expected value of the non diverged individual curve for a given 
spatial frequency. The mean decrease factor (DF) of these 28 eyes was 1.3 
(2 SD 0.6), which is completely within intraindividual variability. 
Patients 
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Figure 4. Mean contrast sensitivity curve of 50 normal eyes. 2 SD (---). 
The mean age of the PD patients was 65 years (range, 52-79). Of the 39 
patients, 16 were in stage I, 20 in stage II, and 3 in stage III (Hoehn & Yahr, 
1967). Eight of the 16 patients in stage I of the disease were given no therapy. 
The remaining eight patients in stage I, and all patients in stages II and III, 
were treated with anticholinergics, amantadine or both. The main initial sign 
was hypokinesia in 20, tremor in 14, and rigidity in five. CS function was obtained 
in 73 eyes of the 39 patients. The remaining five eyes were excluded because 
of concomitant ophthalmological disease (amblyopia, four eyes, and unilateral 
cataract, one eye). The visual acuities of all patients were 7/10 or more, and 
are summarized in Fig. 5. 
The mean normal CS curve was taken as reference for the curves of the 
PD patients. A curve was considered abnormal when the reduction of CS resulted 
in a displacement of (a part of) the curve below the control curve for more 
than two SDs. Intermediate frequency loss was judged abnormal (notch loss) 
when the decrease factor (DF) was more than 1.9, being the mean DF in 28 
of the 50 normal eyes, plus two SDs. 
No. of 
eyes 
60 
40 
20 
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7/10 8/10 9/10 10/10 Visual 
or more acuity 
Figure 5. Distribution of visual acuity in 39 PD patients (73 eyes). 
Of the 39 PD patients, 14 (25 eyes) had normal CS curves. Twenty-five patients 
had abnormal curves, 11 of them unilaterally. High frequency loss (above 3.2 
cycles/ degree) was found in 22 eyes, low spatial frequency loss (below 3.2 cycles/ 
degree) was found in 9 eyes. Sixteen eyes showed notch losses, in eight combined 
with high frequency loss, and in the remaining eight eyes the rest of the curve 
was unaffected. Sixty-nine per cent of the notches were centered at the spatial 
frequencyof0.8 cycles/degree. All notches are summarized in Table 1. Examples 
of abnormal CS function in PD patients are shown in Fig. 6. 
Table 1. Notch losses in 39 patients with Parkinson's disease 
Spatial frequency 
0.6 
0.8 
1.2 
Number of eyes 
3 
11 
2 
Decrease factor 
3.03 
2.94 
4.66 
Abnormal CS was not related to severity of disease, rated according to Hoehn 
and Yahr (1967). CS loss was found in 11 of the 16 patients (70%) in stage 
I, and in 15 of the 20 patients (75%) in stage II. Two of the three patients 
in stage III had abnormal CS functions. No differences were found in the 
PD subgroups with respect to the main initial sign. High frequency loss, low 
frequency loss and notch losses occurred in all stages and subgroups. Unilateral 
abnormality was not related to severity of disease. There was no difference 
in CS function between patients with visual acuities of 7/10 and patients with 
acuities of 10/10 or more. 
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Figure 6. Examples of contrast sensitivity curves of three PD patients, notch loss centered at 0.8 
cycles/ degree spatial frequency, unilateral (A) and bilateral (B and C). 
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DISCUSSION 
Sixty-four per cent of the PD patients had CS loss in one or both eyes. Most 
had high frequency loss, intermediate frequency loss (notch loss), or both (62%). 
Eleven of the 16 notch defects were centered at the 0.8 cycles/ degree spatial 
frequency. The other five notches occurred in the low spatial frequencies as 
well. 
The PD patients had normal subjective visual function, and the visual acuities 
were 7/10 or more. The relationship between visual acuity and CS is complex. 
High frequency loss was seen even in patients with visual acuities of 10/10 
or more and normal curves were found in patients with acuities of 7/10. 
Abnormality of CS was not related to severity of the disease. There were 
no differences in the three subgroups based on the main initial sign. If 
dopaminergic transmission is important in the visual system, it is strange that 
there is no correlation between the severity of PD and abnormality of CS. 
Perhaps the decrease of dopamine levels in the basal ganglia and the visual 
system are not parallel. In addition, the scale according to Hoehn and Yahr 
(1967) is rather crude. 
These data confirm other reports that CS is abnormal in PD. Bodis-Wollner 
et al. (1984) described spatial CS losses in 10 of 12 PD patients over a range 
of spatial frequencies, centered at the region between four and nine cycles/ 
degree. Kupersmith et al. (1982) and Herishanu et al. (1986) also found reduced 
CS in their PD patients. These authors, however, mentioned only mean CS 
scores. It is obvious that notch defects of individual patients cannot be established 
by summation of contrast sensitivities at all spatial frequencies. 
Loss of sensitivity at some spatial frequencies has been reported in other 
neurological disorders. Bodis-Wollner and Diamond (1976) found selective 
frequency loss at intermediate frequency ranges in five patients with occipital 
tumours and in one patient with a posterior cerebral artery occlusion. Notch 
losses have also been seen in MS and optic neuritis (Zimmem et al., 1979; 
Regan et al., 1981; Medjbeur & Tulunay-Keesey, 1985), but marked notch losses 
like those in the patients described here, have never been documented before. 
One could argue whether the notch losses found in this study could not be 
explained by technical factors, such as the alteration of the phase of the grating 
and the measuring of low and high spatial frequencies at different viewing 
distances. These technical factors could not have been responsible for the notch 
defects at the 0.8 cycles/ degree spatial frequency because the place, width and 
the depth of the loss were unchanged when we reexamined some patients 
with a fixed pattern and there was no change of CS at 0.8 cycles/ degree when 
measured at both viewing distances. 
Although simple visual disturbances are not a clinical symptom in PD, peculiar 
visuospatial anomalies have been noted (Bowen, 1976; Boller, 1980; Boller et 
al., 1984). The patients of the present study had no visual symptoms. The site 
of altered visual function in PD is unknown. In animals, there are dopamine 
projections in parts of the peripheral visual system (Haggendal & Malmfors, 
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1965; Deffenu et al., 1967; Phillis et al., 1967; Lindvall et al., 1973; Dyer et 
al., 1981). Dopamine-sensitive cells are also known to exist in the human retina 
(Frederick et al., 1982). Dopamine deficiency or synaptic dysfunction may explain 
abnormalities in VEP studies in PD (Bodis-Wollner et al. 1982). Unilateral CS 
loss, which occurred in 44% of the PD patients, could also imply prechiasmal, 
possibly retinal, involvement. Interocular differences have been found in VEP 
studies as well (Bodis-Wollner & Yahr, 1978; Gawel et al., 1981). The occurrence 
of sensitivity loss at intermediate frequencies in 16 of the 48 "affected" eyes 
in the PD patients, however, may implicate cortical involvement, as spatial 
frequency selectivity is mainly attributed to cortical neurons and not, or only 
in a less degree, to neurons of the retina and geniculate body (Campbell & 
Robson, 1968; Regan, 1982). Grating patterns are optimal stimuli for neurons 
in the visual cortex, in the interpretation of which the association areas play 
an important role. Although the basal ganglia are concerned primarily with 
motor organization, there has been a lot of speculation concerning the 
mechanisms whereby the basal ganglia modulate higher cortical functions 
(Nauta, 1979; Krauthamer, 1979; Koller, 1984). 
In conclusion, abnormal CS function occurs in a high frequency in PD patients. 
Notch losses, which occurred in 30% of the affected eyes, may implicate cortical 
involvement. Regardless of the explanation, the present results are consistent 
with the concept that in PD there is a generalized dopaminergic deficiency 
(Barbeau et al., 1975). 
Part 2. Effect ofLevodopa treatment on contrast sensitivity in Parkinson's disease 
INTRODUCTION 
In part 1 of this Chapter abnormal CS in PD was described, which occurred 
in a considerable proportion (25/39) of patients. Since marked alterations in 
dopamine content occur in brains of parkinsonian patients, CS measurements 
were next conducted on patients in whom we could pharmacologically alter 
the content of monoamines in the central nervous system. Only if dopamine 
is a functional transmitter in the visual pathway, this therapy will change CS 
function. 
SUBJECTS 
The control population of 20 subjects consisted of hospital personnel and 
patients without CNS disease. All had an ophthalmological examination and 
were free of ocular disease. Snellen acuities were 10/10 or better. Ten patients 
with PD who were to start on levodopa substitution were chosen for the 
investigation. They had an ophthalmological examination, including corrected 
visual measurement (Table 2), and were free of ocular disease. Subjects with 
known astigmatism were excluded in both groups. 
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RESULTS 
Control g;roup 
The mean age of the control group was 61 years (range, 53-70). The CS 
functions of the 40 eyes of the control subjects were obtained and the mean 
CS curve is shown in fig. 7. Fourteen eyes (ll subjects) showed a slight decrease 
in CS at intermediate spatial frequencies (between 0.2 and 6.4 cycles/degree). 
The mean decrease factor (DF) of these 14 eyes was 1.3 (2 SD 0.4), which 
is completely within intraindividual variability. 
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Figure 7. Mean contrast sensitivity curve of 40 normal eyes. 2 SD (---). 
Patient g;roup 
The mean age of the 10 patients with PD was 66 years (range, 56-77). The 
visual acuities of all patients were 7/10 or more. The CS function ofthe patient's 
eyes was individually compared with the mean CS curve of the control subjects. 
A curve was judged abnormal when a CS deficit resulted in a displacement 
of (a part of) the curve below the control curve for more than 2 SDs. Intermediate 
frequency loss was considered abnormal (notch defect) when the DF was more 
than 1.7, which was the mean DF in 14 of the 40 normal eyes plus 2 SDs. 
The width of the notch was defined as the spatial frequency band width over 
which CS loss was observed (octaves). Because in the test procedure mostly 
preselected spatial frequencies were used, only an upper limit for the band 
width could be estimated. It is clear that, the more intermediate CS values 
are measured, the more acurately the width of a notch can be estimated. The 
mean width of the notch defects was 1.85 octaves (range, 1.5-2.0). Before levodopa 
treatment, 16 of the 20 eyes (9 patients) had abnormal CS function. Losses 
that could be classified as selective were seen in 11 eyes. The loss affected 
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selectively the high frequency range in five eyes and the low frequency range 
in two eyes. A notch loss was present in four eyes. In two other eyes, notch 
loss was combined with high frequency loss and in another with generalized 
loss. 
The intrasubject variability was measured in four patients (before therapy) 
by retesting CS four to eight weeks following the first test. The mean magnitude 
of variability was only 1.3 (2 SD 0.3), which means a high intrasubject consistency. 
Three to 15 months after the institution of levodopa treatment six of the 
20 eyes (5 patients) still showed abnormal CS curves. After therapy, however, 
only high frequency loss was observed. All other types of deficit had disappeared 
under treatment. The results of the follow-up neuro-ophthalmological exami-
nation of all patients are listed in Table 2. Three examples of CS change (Patients 
5, 8 and 1 0) are shown in Fig. 8. 
Table 2. Clinical data and results ofneuro-ophthalmological investigations in 10 patients with Par-
kinson's disease 
Visual CS before Treatment Follow-up CS after 
No. Sex Age Acuity L-dopa L-dopa (mg) (months) L-dopa 
M 74 R 9/10 h loss 600 4 R h loss 
L 9/10 h loss L no loss 
2 F 56 R 10/10 n loss (0.8) 600 12 R no loss 
L 10/10 n loss (0.8) L no loss 
3 F 64 R 10/10 no loss 375 10 Rno loss 
L 10/10 !loss L no loss 
4 F 67 R 8/10 h loss 1000 3 R h loss 
L 9/10 h loss L h loss 
5 F 67 R 10/10 generalized loss 500 15 Rno loss 
& n loss (0.6) 
L 7/10 generalized loss L h loss 
6 M 64 R 10/10 no loss 300 8 Rno loss 
L 10/10 no loss L no loss 
7 F 64 R 10/10 generalized loss 600 11 R no loss 
L 10/10 !loss L no loss 
8 F 68 R 10/10 h loss & n loss (0.8) 250 10 Rno loss 
L 10/10 h loss & n loss (0.8) L h loss 
9 M 77 R 9/10 h loss 800 12 R h loss 
L 9/10 n loss (0.4) L no loss 
10 M 59 R 10/10 n loss (0.8) 1500 4 R no loss 
L 10/10 no loss L no loss 
cs Contrast sensitivity 
R Right eye 
L Left eye 
!loss Low-frequency loss 
h loss High-frequency loss 
n loss Notch CS loss (spatial frequency, cycles per degree) 
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Figure 8. Three examples of contrast sensitivity change under levodopa treatment (filled circles 
= before levodopa; open circles = after levodopa). 
(A) Patient 5 showed generalized loss in both eyes, in one (right eye) combined with notch loss 
centered at 0.6 cycles/ degree. During treatment, complete normalization occurred except for 
persisting high-frequency loss in left eye. 
(B) Patient 8 had similar contrast losses (high-frequency loss and notch loss centered at 0.8 cycles/ 
degree) in both eyes. During treatment only high-frequency loss in left eye was observed. 
(C) Patient 10 showed unilateral (right eye) notch loss centered at 0.8 cycles/degree, which resolved 
on treatment. 
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DISCUSSION 
Before levodopa treatment, 16 of the 20 eyes showed abnormal CS function. 
Mter treatment, only six of the 20 eyes still showed abnormalities. The only 
patient who had normal pretreatment CS function showed no CS loss after 
levodopa treatment. The change of CS function in this group of patients with 
PD following treatment suggests that dopamine is a functional transmitter in 
the visual pathways. 
Because the motor expression of PD is primarily a reflection of dopamine 
deficiency (Bemheimer et al., 1973), the improvement of motor function after 
levodopa treatment could in theory bias the posttreatment results. This is unlikely, 
as the method of CS measurement used in this study requires very simple motor 
responses. Further, changes in CS function were mostly restricted to a part 
of the frequency range. If improvement of motor function was responsible 
for the posttreatment improvements, a generalized improvement in most cases 
should have been exhibited 
The present findings are supported by related neurophysiological work. Visual 
evoked potential (VEP) studies have shown that abnormal delay could be 
normalized in patients with PD under the influence of levodopa therapy. Bodis-
Wollner and Yahr (1978) showed an abnormal delay with normalization after 
levodopa therapy, in five of 24 patients with PD. Yaar (1980), however, was 
not able to detect significant overall changes in the VEPs in response to levodopa 
treatment. In subsequent studies (Mintz et al., 1981; Bodis-Wollner et al., 1982) 
normalization of abnormal VEPs after levodopa treatment has again been 
demonstrated. 
A substantial proportion of CS loss was restricted to a particular band of 
spatial frequencies. In addition, all intermediate spatial frequency losses ap-
peared rever~ible under levodopa treatment. The existence of selective deficits 
in the pretreatment group might be explained in terms of involvement of cortical 
neurons. In animp.l studies, spatial frequency selectivity for visual stimuli has 
been demonstrated in visual cortical neurons as well as in neurons of the 
retina and lateral geniculate body. Visual cortical neurons, however, are much 
more selective for spatial frequencies than are neurons of the peripheral visual 
system (Campbell et al., 1969; Cooper & Robson, 1968; De Valois et al., 1977; 
1978; 1982). The se"verity of spatial frequency-selective CS losses in patients 
with PD would be most easily explained in terms of involvement of cortical 
neurons. A dopamine deficiency in the mesocortical pathway, as recently 
demonstrated by positron emission tomography (Gamett et al., 1984), could 
cause dysfunction of cortical neurons. J avoy-Agid and Agid (1980) have suggested 
that this deficiency could account for some of the cognitive deficits commonly 
seen in PD. These deficits, however, are not consistently reversible by replacement 
of dopamine. Regardless of the explanation, the present results indicate a 
dependence of CS function on the dopaminergic system in PD. CS loss is 
reversible under levodopa treatment in a considerable proportion of patients 
with PD. 
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Part 3. Effect of stimulus orientation on contrast sensitivity in Parkinson's disease 
INTRODUCTION 
In the previous parts of this chapter it has been demonstrated that a 
considerable proportion of patients with PD had CS loss. A substantial proportion 
of these losses were restricted to a particular band of spatial frequencies, which 
may imply cortical dysfunction. Spatial frequency selectivity is attributed to 
cortical neurons and not, or only to a less degree to neurons of the retina 
and lateral geniculate body (Campbell & Robson, 1969; Regan, 1982). How 
the visual system transforms the retinal neural code into perception is hOt 
known. From animal studies it has been demonstrated that the visual cortex 
is organized in columns with orientation-selective neurons (Rubel et al., 1977; 
1978). Such neurons are almost exclusively at a cortical level (Rubel & Wiesel, 
1968; Bauer et al., 1980). Since dysfunction of the visual cortex may play a 
role in shaping CS loss, we were interested in whether orientation-specific losses 
could be demonstrated in patients with PD. Therefore, the effect of stimulus 
orientation on CS in normal subjects and in patients with PD was studied. 
This was done by measuring CS function over a range of spatial frequencies 
for vertical and horizontal orientations. 
CONTROL SUBJECTS AND PATIETNS 
Control subjects 
The control group of 10 subjects consisted of hospital personnel and patients 
without CNS disease. All had ophthalmological examinations and were free 
of ocular disease. Subjects with known astigmatism were eliminated from the 
control group. Snellen visual acuities, measured with refractive correction where 
necessary, were 10/10 or better. 
Patients with Parkinson's disease 
Twenty-one patients with PD were examined. All had ophthalmological 
examinations, including corrected visual acuity measurements. Patients with 
ocular disease or known astigmatism were excluded. The severity of their disease 
was rated according to Hoehn and Yahr stages categories (Hoehn & Yahr, 
1967). All but one patient were taking anticholinergics, amantadine, or levodopa 
substitution. The only patient who had no therapy was in stage II. 
RESULTS 
Control group 
The mean age of the control group was 68 years (range, 56-84). The CS 
functions of the 20 control eyes were obtained and the mean CS curves for 
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vertical and horizontal stimuli are shown in Fig. 9. It shows that the results 
obtained when the grating was orientated vertically or horizontally were very 
similar. Although intersubject variability was substantial, no orientation-specific 
loss was found. Slight decreases in CS at intermediate spatial frequencies were 
observed using vertical as well as horizontal stimuli. Twelve of the 20 measu-
rements using vertical stimuli showed slight decrements; in a comparable 
proportion (14/20) of the measurements using horizontal stimuli such decre-
ments were observed. These decrements were expressed by their depths (decrease 
factor) and their widths (frequency ranges). The mean decrease factor (DF) 
of26 measurements was 1.2 (2 SD 0.5). 
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Figure 9. Mean contrast sensitivity curve of20 normal eyes for vertical (closed circles) and horizontal 
(open circles) gratings. Lines show 2 SD. 
PD patients 
The mean age of the PD patients was 66 years (range, 53-78). Of the 21 
patients, two were in stage I, 14 in stage II, and five in stage III (Hoehn & 
Yahr, 1967). All but one were treated with anticholinergics, amantadine, levodopa, 
or a combination of these drugs. The visual acuities of all patients were 7/10 
or more. 
The CS function for vertical and horizontal gratings of each of the patients' 
eyes was individually compared with the mean CS curves of the controls. A 
curve was judged abnormal when a CS deficit resulted in a displacement of 
(a part of) the curve below the control curve for more than 2 SDs. Selective 
frequency loss was taken for abnormal (notch defect) when the DF was more 
than 1.7, being the mean DF in the normal group plus 2 SDs. The width 
of the notch was defined as the spatial frequency bandwidth over which contrast 
loss was observed (octaves). Five PD patients were retested one to three months 
later. The magnitude of variability was 1.6 (2 SD 0.3). This test and retest 
consistency included the site, width and depth of the notch defects in these 
patients. 
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CS function was obtained in 42 eyes. Six patients had normal CS functions 
in both eyes for vertical and horizontal gratings. Fifteen patients had at least 
one eye with CS deficit for either stimulus orientation (Table 3). CS for vertical 
orientations was abnormal in 21 eyes. Generalized loss was seen in two eyes. 
Table 3. Type of contrast sensitivity loss in 15 PD patients for vertical and horizontal stimuli 
Type of CS loss 
Generalized loss 
Selective loss 
Notch loss 
Notch loss & low-frequency loss 
Notch loss & high-frequency loss 
Low-frequency loss 
High frequency loss 
Number of eyes 
Vertical stimuli Horizontal stimuli 
2 4 
7 2 
1 
2 I 
6 7 
4 5 
Losses that could be classified as selective were found in 19 eyes (90%). Of 
these 19 eyes, notch losses were present in seven. In two other eyes, notch 
loss was combined with high-frequency loss. The loss affected selectively the 
low-frequency range in six eyes and the high-frequency range in four. The 
mean bandwidth of these 10 notches in nine eyes was 2.4 octaves (range 1.5-3). 
CS for horizontal orientations was abnormal in 20 eyes. Generalized loss 
was observed in four eyes and selective loss in 16 (80%). Low-frequency range 
was selectively affected in seven eyes and the high-frequency range in five. 
A notch loss was present in two eyes and in two other eyes combined with 
other deficits. The mean bandwidth of these four notches was 1.8 octaves (range, 
1.5-2). 
The results of the measurements of CS functions for all patients are shown 
in Table 4. In 17 of the 25 affected eyes, CS loss was confined to only one 
orientation, and in eight eyes CS loss was orientation independent. Of these 
eyes with orientation-independent losses, three showed losses restricted to lower 
spatial frequencies, in two other eyes only high frequency range was affected, 
while in two generalized loss was observed. Twelve of the 19 notch defects 
could only be observed with either stimulus orientation. One patient (case 4) 
had an orientation-selective CS deficit in the right eye while a notch defect 
of two octaves in the left eye narrowed to 1.5 octaves when CS was measured 
with horizontal gratings. Although some patients had similar CS deficits in 
both eyes, orientation-specific losses that were the same in both eyes were 
not seen. Some examples of orientation-specific losses of CS are shown in Fig. 10. 
Abnormal CS was not related to the severity of disease, rated according to 
Hoehn and Yahr (1967). CS loss was found in one of the two patients in stage 
I and in two of the five patients in stage III. Three of the 14 patients in stage 
II had abnormal CS functions with horizontal or vertical stimulus orientation 
in at least one eye. There was no difference in CS function in patients with 
visual acuities of 7/10 and patients with acuities of 10/10 or more. 
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Table 4. Clinical data and results of neuro-ophthalmological investigations in 21 PO patients 
Disease Snellen Contrast sensitivity function 
No. Sex Age stage Therapy acuity vertical stimuli horizontal stimuli 
F 53 III Amantadine R 10/10 no loss no loss 
L 10/10 no loss no loss 
2 F 54 III Amantadine R 10/10 no loss no loss 
L 7/10 no loss no loss 
3 M 55 II A-chol. & R 10/10 n loss (0.2-1.6) no loss 
amantadine L 10/10 n loss (0.4-1.6) h loss 
& h loss 
4 M 55 II A-chol. R 7/10 n loss (6.4-19.2) no loss 
L 7/10 n loss (1.6-6.4) n loss ( 1.6-4.8) 
5 F 56 Levodopa R 10/10 no loss no loss 
L 10/10 no loss no loss 
6 F 59 II A-chol. R 10/10 h loss generalized loss 
L 10/10 generalized loss generalized loss 
7 F 61 III A-chol. R 15/10 n loss (0.4-1.6) no loss 
L 15/10 I loss no loss 
8 M 66 III Levodopa R 15/10 no loss n loss (0.4-1.2) 
& I loss 
L 15/10 no loss no loss 
9 F 66 II Levodopa R 10/10 I loss I loss 
L 7/10 I loss I loss 
10 M 67 II Amantadine R 10/10 no loss no loss 
L 10/10 no loss no loss (0.4-1.6) 
11 F 67 II A-chol. & R 10/10 no loss no loss 
amantadine L 10/10 no loss no loss 
12 M 69 II A-chol. R 10/10 no loss no loss 
L 10/10 no loss no loss 
13 F 69 II Levodopa R 10/10 n loss (3.2-12.8) h loss 
L 7/10 no loss I loss 
14 F 69 II A-chol. R 10/10 no loss no loss 
L 10/10 no loss no loss 
15 M 70 II A-chol. & R 10/10 !loss generalized loss 
amantadine L 10/10 generalized loss generalized loss 
16 F 70 II None R 10/10 no loss I loss 
L 10/10 no loss no loss 
17 M 71 III Amantadine R 7/10 n loss (0.8-6.4) I loss 
& h loss 
L 10/10 I loss I loss 
18 F 72 II Levodopa R 9/10 h loss n loss (0.8-3.2) 
& h loss 
L 9/10 h loss h loss 
19 M 73 I Amantadine R 15/10 no loss no loss 
L 10/10 I loss h loss 
20 M 77 II A-chol. R 10/10 n loss (0.1-0.8) & no loss 
n loss (3.2-12.8) 
L 9/10 n loss (0.8/6.4) !loss 
21 M 78 II Levodopa&R 9/10 h loss h loss 
amantadine L 9/10 no loss no loss 
R Right eye 
L Left eye 
!loss Low-frequency loss 
h loss High-frequency loss 
n loss Notch CS loss 
(spatial frequency, cycles per degree) 
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Figure 10. Examples of contrast sensitivity cuiTes in five PD patients. Key to symbols as in figure9. 
Case 3 shows n loss (0.2-1.6) in right eye and n loss (0.4-1.6) in left eye for vertical gratings 
only and persisting h loss in left eye, stimulus independenL 
Case 4 shows orientation-specific loss (6.4-19.2) in right eye, while n loss (1.6-6.4) in left eye narrows 
to 1.6-4.8 when CS is measured with horizontal gratings. 
Case 6 shows orientation-independent generalized loss in left eye and orientation-specific loss 
for all spatial frequencies except high-frequency range in right eye. 
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Figure 10 continued 
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Case 8 shows ·n loss (0.4-1.2) and I loss in right eye for horizontal gratings only and normal 
CS curves in left eye for both orientations. 
Case 18 shows_ orientation-specific n loss (0.8-3.2) in right eye and orientation-independent h loss 
in both eyes. 
l loss = low-frequency Joss; h loss = high-frequency loss; n loss = notch loss (spatial frequency 
range in cycles/degree). 
DISCUSSION 
Study of CS function with grating stimuli of different orientations showed 
CS deficit in 15 of the 21 PD patients in at least one eye. All patients had 
visual acuities of 7/10 or more. This means that CS measurments can 
demonstrate disturbances of visual function despite a good visual acuity. More 
importantly, CS measuring for different orientations revealed that 17 of the 
25 affected eyes showed orientation-selective deficits. The most frequent type 
of orientation-selective loss, observed in 12 cases, was a notch defect, which 
preferentially affected the middle spatial frequencies. These defects were mostly 
asymmetrical and in some only one eye was affected. 
In a previous part of this chapter the results of CS measurements in 39 
PD patients were described. A considerable proportion (25/39) of these patients, 
tested with vertical gratings only, had abnormal CS function. The present study 
verifies and extends these findings by testing CS by variable stimulus orientations. 
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These data confirm earlier reports that CS is abnormal in PD patients. Bodis-
Wollner et al. (1984) described spatial CS losses in 10 PD patients. Specific 
losses in sensitivity were observed near the peak of the spatial CS curve, often 
with no noticeable low frequency attenuation. These authors used only vertical 
orientations to test CS function. Regan and Maxner (1987) reported also 
orientation-dependent CS loss in six of 10 PD patients. Because they measured 
CS using temporally modulated stimuli, their findings cannot be compared with 
the data of this study. Nevertheless, they also concluded that orientation selectivity 
implicates visual cortical cells. Kupersmith et al. (1982) and Herishanu et al. 
(1986) also found reduced CS in their PD patients. These authors, however, 
mentioned only mean CS scores. It is obvious that intermediate and orientation-
specific CS losses of individual patients cannot be established from the averages 
of CS curves showing diverse, multifocal types of disturbances. Moreover, it 
should be noted that intersubject variability ofCS is substantial in control subjects 
as well as in patients. A fundamental assumption implicit in diagnosing CS 
deficits is a subject's test and retest consistency. The intrasubject variability was 
measured in five PD patients by retesting CS one to six months later. The 
mean magnitude of variability was only 1.6 (2 SD 0.3), which means a great 
intrasubject test-retest consistency. The site, width and depth of the notch defects 
were highly reproducible. 
An intriguing question concerns the site of orientation-specific pathology. 
Although recent work suggests that some grating orientation tuning exists in 
retinal ganglion cells (Hammond, 1974; Levick & Thibos, 1980) and in the 
lateral geniculate bodies (Vidyasagar & Urbas, 1982; Albus et al., 1983), 
orientation-selective CS loss in PD must be attributed to functional disruption 
of cortical neurons because orientation-selective neurons are not found pe-
ripheral to the visual cortex. Hubel et al. (1977; 1978) have demonstrated that 
the visual cortex is organized in columns with orientation-selective neurons. 
Although there is no direct evidence that orientation-selective neurons have 
anything to do with visual perception, it is attractive to assume that this functional 
architecture represents some stage in the analysis of visual forms. Whether 
or not peripheral effects contribute to CS loss in PD remains to be established. 
Bodis-Wollner et al. (1984) suggested an abnormality in monocular excitatory-
inhibitory interactions of the visual system to explain CS loss in PD. Indeed, 
CS defects are often asymmetrical and in some monocular. In visual evoked 
potential (VEP) studies, asymmetrical results have also been reported in PD 
(Bodis-Wollner & Yahr, 1978; Bodis Wollner et al., 1980); Gawel et al., 1981; 
Mintz et al., 1981; Bodis-Wollner et al., 1982). NeuropJ;lysiologic studies have 
demonstrated, however, that identical stimuli do not usually give quantitatively 
identical reponses if first one eye and then the other one is tested (Hubel 
& Wiesel, 1979). Asymmetrical CS deficits and VEP asymmetry therefore are 
not necessarily explained by monocular disturbances. 
PD is due to a generalized dopaminergic deficiency (Barbeau et al., 1975). 
The main source for dopaminergic influences on a cortical level arises from 
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the basal ganglia via the mesocortical dopaminergic pathway (Moore & Bloom, 
1978). Degeneration of these dopamine fibers in PD gives rise to cortical 
dopamine deficiency. Positron emission tomographic studies in PD patients 
(Garnett et al., 1984) have demonstrated that dopamine concentrations are also 
decreased in the visual cortex. The role of dopamine in cortical neurons might 
be important in normal visual function. A functional disruption of these 
dopamine-containing neurons in PD may play an important role in generating 
frequency-selective and orientation-specific CS loss. 
In summary, the following conclusions can be drawn: (1) CS loss in PD 
is orientation-selective in a considerable proportion of patients, and (2) the 
responsible disturbance for spatial frequency-selective and orientation-specific 
loss is, at least in part, situated at, or central to the primary visual cortex. 
Part 4. Contrast sensitivity loss in drug-induced Parkinsonism 
INTRODUCTION 
In the previous parts of this Chapter it was found that a considerable 
proportion (25/39) of patients with Parkinson's Disease (PD) had visual Contrast 
Sensitivity (CS) loss. The reversibility of CS losses under levodopa treatment 
suggested a dependence of visual function on dopaminergic transmission. Drug-
induced Parkinsonism (DIP) is a generalized condition that resembles PD 
clinically and biochemically. If dopamine is a functional transmitter in the 
visual pathway, systemic administration of dopamine blockers will, in theory, 
affect CS function in a similar way as in PD. In this study, we evaluated CS 
function in 1 0 patients with DIP. 
SUBJECTS 
Control subjects 
The control group comprised 10 subjects, none of whom had any history 
of neurological or ophthalmological disorder. Subjects with known astigmatism 
were excluded. All had ophthalmological examination and were free of ocular 
disease. Snellen acuities, measured with refractive correction where necessary 
were 10/10 or better. 
Patients 
Ten previously untreated patients, who were alert, were selected. They were 
all receiving dopamine blockers (haloperidol and/ or fluspirilene) for at least 
three weeks at the time of testing. All patients had drug-induced parkinsonism, 
the severity of which was rated according to Hoehn and Yahr's stages categories. 
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Clinical summaries and medication are listed in Table 5. To exclude possible 
effects of sedation on CS testing in the patient group, we also examined three 
age-matched epileptic patients receiving phenytoin (dose 300 mg/day). All 
patients had ophthalmological examination, including corrected visual acuity 
testing. Patients with known astigmatism were excluded. 
Table 5. Clinical summaries of 10 patients with drug-induced Parkinsonism 
No. Sex Age Medication* Psychiatric diagnosis 
(yrs) H B F 
l f 17 15 5 Schizophrenia 
2 m 21 5 5 Schizophrenia 
3 f 22 2.5 Puerperal Psychosis 
4 f 25 2.5 Puerperal Psychosis 
5 m 35 5 4 Schizophrenia 
6 m 38 5 Manic-depressive Psychosis 
7 m 39 5 Schizophrenia 
8 f 40 5 5 10 Schizophrenia 
9 m 42 10 Melancholia 
10 f 51 10 5 Schizophrenia 
*haloperidol (H) and benzhexol (B) in daily dose (mg); fluspirilene (F) in weekly dose (mg). 
RESULTS 
Control group 
The mean age of the control group was 35 years, (range, 23-51). The CS 
functions of the 20 control eyes were obtained for vertical and horizontal gratings 
and the mean CS curves for both orientations are shown in Fig. 11. Close 
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Figure 11. Mean contrast sensitivity curve of20 normal eyes for vertical (filled circles) and horizontal 
gratings (open circles). Lines show 2 SD. 
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inspection of individual CS curves in normal subjects can reveal that at 
intermediate spatial frequencies a CS curve can diverge slightly from the pure 
inverted U shape. Minor deflections at intermediate spatial frequencies were 
observed for vertical as well as horizontal stimuli. In 12 ofthe 20 measurements 
using vertical stimuli slight decrements were found, while in 10 of the 20 
measurements using horizontal stimuli such decrements were observed. These 
decrements were expressed by their depths (decrease factor) and their widths 
(frequency ranges). The mean decrease factor (DF) of the 22 measurements 
was 1.2 (2 SD 0.2). These slight decrements in the individual CS function of 
the controls are completely within intrasubject variability. 
Patient group 
The mean age of the patient group was 33 years, (range, 17-51). All patients 
had Snellen acuities of 10/10 or better. Rated according to Hoehn and Yahr 
they were all in stage II. The CS function for vertical and horizontal gratings 
of each of the patient's eyes was individually compared with the mean CS 
curves of the controls. A curve was judged abnormal when a CS deficit resulted 
in a displacement of (a part of) the curve below the control curve for more 
than two standard deviations. Intermediate frequency loss was taken for 
abnormal (notch defect) when the decrease factor (DF) was more than 1.4, 
being the mean D.F. in the normal group plus two standard deviations. The 
width of the notch was defined as the spatial frequency bandwidth over which 
contrast loss was observed (octaves). Two of the ten DIP patients were retested 
four weeks later. The magnitude of variability was 1.5 (2 SD 0.3). This test 
and retest consistency included the site, width and depth of the notch defects 
in these patients. CS function was obtained in 20 eyes. Only one patient had 
normal CS functions in both eyes for vertical and horizontal gratings. All other 
nine patients had at least one eye with CS deficit for vertical and/ or horizontal 
stimuli. Six of these nine patients had some CS losses in both eyes. The different 
types of CS loss for all patients are shown in Table 6. CS losses affecting all 
the spatial frequencies tested were observed in both eyes of patient no. 9. These 
deficits are referred to as generalized losses. All other CS losses were spatial 
frequency-selective. The most frequent type of deficit, observed in 14 eyes, was 
a notch loss. In two eyes multifocal notch losses were found and in four other 
eyes they occurred in combination with other types of loss. Seventeen of the 
total number of 19 notches for either stimulus orientation occurr.::d in the 
middle and low spatial frequency range (below 32. cycles/degree). Other types 
of spatial frequency selective CS loss were seen in three eyes. The loss affected 
selectively the high spatial frequency range in one eye, and the low spatial 
frequency range in two eyes. Although there was some overlap concerning 
orientation specificity in two eyes (no. 4, 5), all spatial frequency-selective CS 
deficits were orientation dependent. The generalized losses in both eyes of 
patient no. 9 were orientation independent. Some examples of orientation-
specific CS losses are shown in Fig. 12. The three epileptic patients all receiving 
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Table 6. Contrast sensitivity function for vertical and horizontal stimuli in 10 patients treated with 
dopaminergic blockers 
CONTRAST SENSITIVITY 
No. Vertical Stimuli Horizontal Stimuli 
R n loss (0.4-1.6) & h loss no loss 
L n loss ( 0.8-3.2) no loss 
2 R no loss no loss 
L no loss no loss 
3 R n loss (3.2-12.8) no loss 
L n loss (0.1-0.4) no loss 
4 R no loss n loss (0.1-0.4) & (0.4-1.6) 
L n loss (0.2-1.6) n loss (0.1-0.8) 
5 R n loss (0.2-1.6) no loss 
L n loss (0.8-3.2) n loss (0.4-3.2) 
6 R no loss no loss 
L no loss n loss (0.8-3.2) 
7 R n loss (0.8-3.2) no loss 
L no loss no loss 
8 R n loss (0.4-1.6) n loss (1.6-6.4) 
L no loss no loss 
9 R generalized loss & n loss generalized loss 
(0.2-0.8) & (0.8-3.2) 
L generalized loss generalized loss & 
n loss (0.8-3.2) 
10 R !loss no loss 
L !loss & n loss (0.4-3.2) no loss 
Key to symbols as in table 4. 
phenytoin (300 mg/ day) had nonnal curves for vertical as well as horizental 
stimuli. 
DISCUSSION 
Sine-wave grating CS detenninations for vertical and horizontal orientations 
revealed CS loss in 9 of the 10 patients with DIP. The most frequent type 
of deficit, observed in 14 eyes was a notch loss, which preferentially affected 
the middle and low spatial frequencies. All spatial frequency-selective CS loss 
was orientation dependent. Generalized loss, found in two eyes was orientation 
independent. 
In the first part of this Chapter it was demonstrated that abnonnal CS function 
occurred in a high frequency in PD. In part 3, it was shown that these losses 
were greatly stimulus orientation-dependent. The most frequent type of CS loss 
was also a notch defect, which especially affected the middle spatial frequencies. 
In a recent study by Regan and Maxner (1987), who used temporally modulated 
stimuli at one spatial frequency (2 cycles/degree), orientation-selective loss was 
also demonstrated in 6 ofl 0 PD patients. CS loss was most marked at a temporal 
frequency of 4 to 8 Hz. The maximum of CS loss was found for horizontally 
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Figure 12. Examples of contrast sensitivity curves in 4 patients with drug-induced Parkinsonism. 
Key to symbols as figure 11. The upper pan of each figure shows the ratio of the altered contrast 
sensitivity to normal contrast sensitivity function for corresponding spatial frequencies. 
(A) Patient 4. Left eye shows orientation-specific notch losses: a 3 octaves wide notch loss for 
horizontal gratings centered at 0.2 cycles/ degree and a 3 octaves wide notch loss for venical gratings 
at 0.8 cycles/degree. Right eye shows a notch loss centered at 0.2 cycles/degree and another notch 
loss centered at 0.8 cycles/degree for horizontal gratings only. Both notches are 2 octaves wide. 
(B) Patient 5. Left eye shows a notch loss (0.4-3.2), which narrows to 0.8-3.2 when CS is measured 
with venical gratings. Right eye shows orientation-specific, 3 octaves wide notch loss centered 
at 0.6 cycles/ degree for venical gratings. 
Figure 12 continued 
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(C) Patient 8, Left eye shows normal curves for both orientations, Right eye shows a 2 octaves 
wide notch loss centered at 0-8 and another of the same width at 3,2 cycles/ degree, both orientation-
specific, for vertical and horizontal gratings respectively, 
(D) Patient 9, Both eyes show orientation-independent generalized loss, Left eye shows also a 
2 octaves wide orientation-selective notch loss centered at L6 cycles/ degree, Right eye shows beside 
generalized loss a notch loss centered at OA and another notch loss centered at 3,2 cycles/degree, 
both 2 octaves wide and orientation-selective, 
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orientated stimuli. They proposed a possible explanation of their findings based 
on animal studies. In the visual cortical area V2 in the baboon there is a 
marked bias for neurons to prefer vertically orientated stimuli, while in area 
VI there is a roughly similar preference for horizontal and vertical orientations 
(Kennedy et al., 1985). Patients with a selective loss of CS for horizontal stimuli 
might have selective damage to the human equivalent of VI striate cortex. 
Although comparison of the data of the present study with their findings is 
rendered difficult because of different techniques of CS measurement, the 
selective loss of CS for horizontal stimuli was not encountered in our results 
ofPD and DIP patients. The roughly equal CS losses for vertically and horizontally 
orientated stimuli, on the contrary, might indicate involvement of other visual 
cortical areas than the human equivalent of VI striate cortex. Spatial and 
temporal 'channels of vision' can apparently be affected differentially in a variety 
ofways in PD. 
A major assumption implicit in diagnosing CS deficits is the intrasubject 
test-retest consistency. We measured this by retesting CS in three DIP patients, 
four weeks later. The mean magnitude of variability was only 1.5 (2 SD 0.3), 
which means a great test-retest consistency. The site, width and depth of the 
notch defects were highly reproducible. To minimize any possible effect of 
sedation on CS testing in our DIP patient group we also examined three epileptic 
patients receiving 300 mg phenytoin per day. All three patients showed normal 
CS curves for vertical and horizintal grating stimuli. 
Patients treated with neuroleptics like butyrophenones (haloperidol) and 
diphenylbutylpiperidines (fluspirilene) may develop a clinical picture which 
mimics PD very closely. DIP and PD are two conditions that share pharmacologic 
(Ambani et al., 1973), and biochemical (Chase et al., 1970) characteristics. The 
fact that DIP is mainly produced by drugs that interfere with storage of dopamine 
pre-synapticly, or block post-synaptic dopamine receptors, indicates that "do-
pamine deficiency" is the biochemical basis of this clinical condition. PD and 
DIP are classically associated with motor manifestations, but the disorders are 
probably more generalized (Barbeau et al., 1975). Abnormalities of visual evoked 
potentials (Bodis-Wollner & Yahr, 1978; Gawel et al., 1981; Bodis-Wollner et 
al., 1 982) and CS function in PD indicate that the visual system is also.involved. 
There is a striking resemblance of the pattem of CS loss in drug-induced 
Parkinsonism to that in PD. This curious parallel suggests that generalized 
dopaminergic hypofunction, from whatever cause, has similar effects on visual 
function. The present results, once again support the view that dopamine is 
a functional transmitter in the visual pathway. 
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Chapter III 
CONTRAST SENSITIVITY IN UNILATERAL CEREBRAL 
ISCHAEMIC LESIONS INVOLVING THE 
POSTERIOR VISUAL PATHWAY 
INTRODUCTION 
The organization of the posterior visual pathway is known in general outline, 
but little is known about details of topography, and what perceptual deficits 
may occur under pathological circumstances. Acuity tests, as measured with 
the Snellen letters, are good means for the detection of optic nerve and chiasma! 
disorders. However, they have no value in the detection of unilateral lesions 
of the posterior visual pathway (Frisen, 1980) .. Acuity remains normal as long 
as either the crossing or the non crossing neural outflow from the retinal 
fovea remains intact 
Nevertheless, in spite of clinically normal visual acuity patients with cerebral 
lesions may complain of blurred vision (Bodis-Wollner & Diamond, 1976). Such 
patients might have a peculiar sort of visual disturbance, reducing central visual 
function, without affecting visual acuity. Such neurally caused visual disturbances 
could be revealed by a more extensive test of central vision, determinations 
of spatial contrast sensitivity (CS). 
Electrophysiological studies of single cells in the animal brain and psycho-
physical investigations of the human visual system have demonstrated that there 
might be parallel channels in the visual system, selectively responding to different 
spatial frequencies (Enroth-Cugell & Robson, 1966; Campbell & Robson, 1968; 
Campbell et al., 1969; Blakemore & Campbell, 1969; Albrecht et al., 1980). 
The overall bandwidth of frequencies narrows from the retina to the striate 
cortex where 'simple' cells have the narrowest bandwidth (Maffei et al., 1973). 
This approach to vision assumes the existence of subsystems operating in parallel 
channels, each channel carrying a limited range of spatial frequencies. Func-
tional disruption or anatomical lesions of the posterior visual pathway could 
selectively damage some frequency-selective channels, while the others continue 
to function normally (Regan et al., 1977; 1980; 1981). Such lesions can implicate 
central visual function, without affecting visual acuity. CS examination as a 
function of spatial frequency might designate which part of the spatial frequency 
range is affected by different lesions comprising the posterior visual pathway. 
Another issue, concerning properties of neurons subserving central visual 
function, is orientation selectivity. Striate cortex neurons are not only sensitive 
to restricted ranges of spatial frequencies, they also appear sensitive to the 
orientation of the stimulus. Hubel et al. (1977; 1978) have demonstrated that 
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orientation selective neurons are organized in columns in the primary visual 
cortex. These orientation-sensitive neurons are not found peripheral to the 
primary visual cortex in primates. Orientation-selective CS loss, which has been 
described in multiple sclerosis (Regan et al., 1980; Kupersmith et al., 1984) 
and Parkinson's disease (Regan & Maxner, 1987; Bulens et al., 1988a) have 
been explained therefore, in terms of involvement of cortical neurons. It is 
not surprising that true anatomical lesions of the posterior visual pathway can 
also generate abnormal CS function (Bodis-Wollner & Diamond, 1976; Kobayashi 
et al., 1985). Measurements of spatial CS function for different orientations 
:n this group of patients could yield information about visual perceptual deficits, 
not obtainable by conventional visual tests. 
In this Chapter, CS function in patients with unilateral ischaemic lesions 
involving the posterior visual pathway is described. An important question was 
whether CS function was affected in a qualitative different way according to 
the site of the lesion, and whether orientation-selectivity was restricted to lesions 
of the primary visual cortex. 
SUBJECTS 
The control group consisted of 10 subjects without CNS disease. All were 
free of ocular disease. Subjects with known astigmatism were excluded. Snellen 
acuities, measured with refractive correction where necessary, were 10/10 or 
better. This group had a mean age of 68 years (range, 56-84). 
Sixteen patients, all having visual field defects consistent with unilateral 
cerebral ischaemic lesion and confirmed by CT scanning were selected. The 
duration after onset varied from three days to 10 years. All patients had 
ophthalmological examination, including corrected visual' acuity measurement 
and Goldmann perimetry. Patients with retinal abnormalities, lens opacity, or 
known astigmatism were excluded. The mean age of the patients was 65 years 
(range, 53-77). The patients were classified according to the site of the lesion: 
occipital and occipitotemporallesions (group I); temporal and parietal lesions 
(group II). Location and extent of lesions were determined from CT scans, 
referring to standard atlases (Gado et al., 1979). Clinical summaries are given 
in the Tables 7 and 8. 
RESULTS 
Control group 
The CS functions of the 20 control eyes were obtained and the mean CS 
curves of the control group for vertical and horizontal stimuli are shown in 
Fig. 13. Close inspection of individual CS curves in normal subjects can reveal 
that at intermediate spatial frequencies a CS curve can diverge slightly from 
the pure inverted U shape. Such minor deflections of the CS curve at intermediate 
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spatial frequencies were observed for vertical as well as horizontal stimuli. In 
twelve of the 20 measurements using vertical stimuli slight decrements were 
found, while in 14 of the 20 measurements using horizontal stimuli such 
decrements were observed. The decrease factor (DF) of these decrements was 
defined as the ratio of the measured CS and the expected value of the non 
diverged individual curve for a given spatial frequency. The mean decrease 
factor (DF) of 26 measurements was 1.2 (2 SD 0.5). These slight decrements 
in the individual CS function of the controls are completely within intrasubject 
variability. There was no orientation specific CS loss within the spatial frequency 
range. 
~ 
> 
1000 
i= 100 
Ci5 
z 
UJ 
({) 
b; 
<( 
c:: 
f-
z 
0 (.) 10 
0.1 1.0 10 100 
SPATIAL FREQUENCY C/degree 
Figure 13. Mean contrast sensitivity curve of20 normal eyes for vertical (filled circles) and horizontal 
gratings (open circles). Lones show 2 SD. 
Patients 
The CS function for vertical and horizontal gratings of each of the patient's 
eyes was individually compared with the mean CS curves of the controls. A 
curve was judged abnormal when a CS deficit resulted in a displacement of 
(a part of) the curve below the control curve for more than two standard 
deviations. Intermediate frequency loss was taken for abnormal (notch defect) 
when the decrease factor (DF) was more than 1.7, being the mean DF in the 
normal group plus two standard deviations. The width of the notch was defined 
as the spatial frequency bandwidth over which contrast loss was observed 
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(octaves). CS function was obtained in 32 eyes. Six patients had normal CS 
functions in both eyes for vertical and horizontal gratings. Of these six patients 
five were in group I, and one patient in group II. Ten patients had at least 
one eye with CS deficit for either stimulus orientation. Three of these 10 patients 
had a unilateral CS deficit for both stimulus orientations. The different types 
of CS loss for all patients are shown in Table 7. Contrast loss was confined 
Table 7. Investigations in 16 patients with unilateral ischaemic lesions of the posterior visual pathway. 
Group I: Occipital and Occipitotemporallesions, Group II: Temporal and Parietal lesions 
Case Sex Age Duration Visual Visual Contrast Sensitivity Function 
No. after Onset Field Acuity Vertical Stimuli Horizontal Stimuli 
GROUP I 
m 68 1 month uu R: 10/10 no loss no loss 
L: 7/10 h loss no loss 
2 m 60 10 years ()() R: 10/10 no loss no loss 
L: 10/10 no loss no loss 
3 m 77 3 days ()() R: 10/10 no loss no loss 
L: 7/10 no loss no loss 
4 m 58 2 months ()() R: 10/10 no loss n loss(6.4-19.2) 
L: 10/10 n loss(9.4-19.2) no loss 
5 m 53 3 weeks ~~ R: 10/10 no loss no loss 
L: 10/10 no loss no loss 
6 m 53 2 weeks ()() R: 10/10 no loss no loss 
L: 10/10 no loss n loss(3.2-12.8) 
7 61 9 months ()() R: 15/10 no loss no loss 
L: 15/10 no loss no loss 
8 75 1 month ~~ R: 10/10 no loss no loss 
L: 8/10 no loss no loss 
9 72 18 months QQ R: 10/10 n loss(6.4-19.2) no loss 
L: 10/10 no loss n loss(6.4·19.2) 
GROUP II 
10 m 72 2 months uu R: 8/10 n loss(0.2-0.8) I loss 
L: 7/10 I loss I loss 
11 m 56 6 weeks ()() R: 10/10 no loss no loss 
L: 10/10 no loss n loss(0.2-3.2) 
12 m 67 1 month uu R: 10/10 n loss(0.2·0.8) no loss 
L: 10/10 n loss(0.2·1.6) n loss(O.S-3.2) 
13 m 53 3 months ~~ R: 10/10 no loss no loss 
L: 10/10 no loss no loss 
14 66 2 weeks ~~ R: 10/10 no loss n loss(O.S-3.2) 
L: 8/10 n loss(0.4-1.6) no loss 
15 m 73 2 years ()() R: 10/10 I loss no loss 
L: 10/10 I loss n loss(0.2-0.8) 
16 76 4 years G~ R: 7/10 I loss I loss 
L: 7/10 no loss no loss 
Key to symbols as in table .4. 
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to one eye for either stimulus orientation in two patients. CS loss was spatial 
frequency-selective in all 'affected' eyes. Two patients (case 10 and 16) showed 
a stimulus independent low frequency loss in one eye, all other CS deficits 
were orientation dependent. We measured the intrasubject variability in three 
patients, by retesting CS two to three weeks later. The mean magnitude of 
variability was only 1.3 (2 SD 0.4), which means a great intrasubject test-retest 
consistency. The locations of the isachemic lesions are summarized in Table 
8, with particular emphasis on the visual cortical areas involved. 
Table 8. Location and extent ofischaemic lesions in 16 patients 
Case no. 
Group 1 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Group 2 
10 
11 
12 
13 
14 
15 
16 
Location (Brodmann Areas) 
17, 18 
17, 18, 19, 23,31 
17, 18 
17, 18,19,20,37 
17, 18, 19 
17, 18, 19 
17, 18 
18, 19 
17 
22,28 
21,22,37 
20,28,34,35,37 
20,21,38,39,40 
Temporal genu of right optic radiation 
39,40 
39,40 
Group I: occipital and occipitotemporallesions 
Four of the nine patients in this group had abnormal CS function in at 
least one eye for either stimulus orientation. All six 'affected' eyes showed 
preferential loss at high spatial frequencies (above 3.2 c/d). Five of these six 
eyes showed a notch loss in the frequency range 3.2 to 19.2 c/ d. The mean 
bandwidth of these notches was 1.5 octaves (range, 1-2 octaves). All CS deficits 
were stimulus orientation dependent. Involvement of Brodmann's cortical area 
17 was observed in seven of the nine patients (Table 8). All four patients with 
abnormal CS curves had involvement of Brodmann's cortical area 17 (striate 
cortex). Three patients with normal CS function, however, had also lesions 
of the striate cortex. Both patients with lesions of the peri-striate areas (case 
7 and 8) and sparing of the primary visual cortex, had normal CS functions 
for both orientations in right and left eye. Fig. 14 shows examples of orientation 
dependent CS loss in two patients. Case 4 illustrates orientation dependent CS 
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loss in both eyes. A notch defect with a bandwidth of 1.5 octaves in the right 
eye for horizontal gratings and a notch defect of 1 octave in the left eye for 
vertical gratings. Both notches were centered at 12.8 c/d Case 6 shows a notch 
loss centered at 6.4 c/ d with a bandwidth of two octaves in the left eye for 
horizontal gratings only, and normal CS curves for both orientations in the 
right eye. 
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Figure 14. Contrast sensitivity curves and CT scans of a patient with a left sited occipitotemporal 
infarction (Case 4) and of a patient with a left sited occipital lesion (Case 6). Key to symbols 
as in figure 13. Orientation dependent CS loss in the high spatial frequency range, bilateral (Case 
4) and unilateral (Case 6). 
Group II· temporal and parietal lesions 
Six of the seven patients in this group had abnormal CS function in at least 
one eye for either stimulus orientation. Ten of the 14 eyes showed CS loss 
at low spatial frequencies (below 3.2 c/ d), all but two, orientation-dependent. 
Notch defects (frequency range 0.2-3.2 c/ d) were seen in seven eyes, all stimulus 
orientation-dependent. The mean bandwidth was 2.5 octaves (range, 2-4). All 
seven patients had no direct involvement of the striate cortex (Table 7). Eight 
of the 10 CS deficits, however, were nevertheless stimulus orientation-dependent. 
Detailed findings in three cases are shown in Fig. 15. Case 10 shows a notch 
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defect of two octaves centered at 0.4 c/ d for vertical stimuli and low frequency 
loss for horizontal stimuli in the right eye. Stimulus orientation independent 
low frequency loss was seen in the left eye. Case 14 shows a notch defect 
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Figure 15. Contrast sensitivity cutves and CT scans for Cases 10, 14 and 15. Arrow indicates right 
subinsular infarction, affecting the genu of the right optic radiation (Case 14). Case 10 shows 
stimulus independent low frequency loss in the left eye, and stimulus dependent notch loss centered 
at 0.4 cycles/ degree in the right eye. Both stimulus dependent notch losses in Case 14 are also 
in the bw spatial frequency range. Case 15 shows orientation dependent low frequency loss in-
both eyes and a stimulus dependent notch loss at 0.4 cycles/degree in the left eye. 
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of 2 octaves wide, centered at 0.8 c/ d, in the left eye for vertical gratings and 
a 2.5 octaves wide notch defect centered at 1.2 c/ d in the right eye for horizontal 
gratings. Case 15 is an example of a patient with a parietal infarction. Orientation-
dependent low frequency CS loss was demonstrated in both eyes for vertical 
gratings, and a notch defect with a bandwidth of 2 octaves centered at 0.4 
c/ d was observed in the left eye for horizontal gratings. Clinical data of all 
patients are listed in the Table 7. 
DISCUSSION 
Spatial CS function, elicited by sinewave gratings in 16 patients with unilateral 
ischaemic lesions involving the posterior visual pathway was abnormal in 10 
patients. All patients had visual acuities of 7/10 or more. Visual perception 
was distorted in a qualitatively different way according to the site of the lesion. 
Visual losses restricted to medium and high spatial frequencies were confined 
to occipital and occipitotemporal lesions. Low spatial frequency losses were 
only seen in patients with temporal and parietal lesions. The mean width of 
the notch defects narrowed from 2.5 octaves (range, 2-4) in patients with temporal 
and parietal lesions to 1.5 octaves (range, 1-2) in patients with lesions affecting 
the visual cortex. Anatomical lesions of the posterior visual pathway can damage 
neurons with a restricted spatial frequency range, while others continue to 
function normally. 
The CS measured for different orientations revealed that 14 of the 17 'affected' 
eyes showed orientation dependent visual loss. This stimulus orientation se-
lectivity was observed in patients with lesions of the striate cortex as well as 
in patients with lesions anterior to the primary visual cortex. In three patients 
the CS los:> was confined to only one eye for either stimulus orientation. It 
is possible that CS measurements with more than vertical and horizontal stimuli 
may reveal more binocular CS deficits than those encountered in this study. 
These data confirm earlier reports of abnormal visuospatial CS due to cerebral 
lesions. Bodis-Wollner and Diamond (1976) found impairment of CS in 35 
patients with cerebral lesions of heterogeneous aetiology. Four of these had 
unilateral posterior ischaemic lesions. Uniform loss was established in two 
patients, high frequency loss in one patient and notch losses at six and 14 
c/ d were present in another patient. They concluded that cerebral lesions 
involving the human visual system have non-uniform effects on central vision. 
Kobayashi et al. ( 1985) studied CS function in 23 patients with cerebral infarctions 
involving the posterior visual pathway. They found abnormal CS function 
especially in patients with lesions of the nondominant parieto-occipital cortex. 
Their results are unfortunately based on the Arden grating test (Arden, 1978). 
This method generates substantial intrasubject variability. Moreover, their curves 
of CS function are almost flat, indicating a lack of difference in CS for low, 
intermediate and high spatial frequencies. Their data are in disagreement with 
the results obtained by all previous reports concem"ing CS measurements. 
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From psychophysical investigations of the human visual system and elec-
trophysiological studies of single cells in the animal brain, many authors have 
proposed that visual input is processed via spatial frequency channels of unequal 
sensitivity (Enroth-Cugell & Robson, 1966; Campbell & Robson, 1968; Campbell 
et al., 1969; Blakemore & Campbell, 1969; Albrecht et al., 1980). According 
to this view, it has been suggested that the channels carrying low spatial 
frequencies have dissimilar characteristics from those dealing with high spatial 
frequencies (Lennie, 1980; Graham, 1981). The present results seem relevant 
to the channel hypothesis. When it is assumed that the selective spatial CS 
losses in our patient groups indicate a dysfunction of one or more channels 
of a restricted range of spatial frequencies, lesions at different sites of the posterior 
visual pathway apparently affect different spatial frequency channels. In this 
study the affected spatial frequency range was systematically related to the 
anteroposterior site of the lesion. Contrast losses for spatial frequencies above 
3.2 c/ d were only observed in patients with occipital and occipita-temporal 
lesions and losses for spatial frequencies less than 3.2 c/ d in patients with 
temporal and parietal lesions. Neural mechanisms in the anterior part of the 
postchiasmal visual pathway seem selectively sensitive (tuned) to, low spatial 
frequencies, while high frequency tuning might exist in the posterior part, at 
the level of the primary visual cortex. 
Visual neurons may be viewed as neural filters of visual signals, and spatial 
filtering properties can be measured by determining CS for a range of spatial 
frequencies. In animal studies spatial frequency selectivity for visual stimuli 
has been demonstrated in visual cortical neurons as well as in neurons of 
the retina and lateral geniculate body. Cortical neurons, however, are much 
more selective for spatial frequencies (highly tuned) than neurons of retina 
or lateral geniculate body (Cooper & Robson, 1968; Campbell et al., 1969; Maffei 
et al., 1973; De Valois et al., 1977; 1978; 1982). The degree of spatial tuning 
can be quantified in terms of the width of the spatial frequency selective CS 
loss (notch defect). These bandwidths are usually expressed in octaves. From 
electrophysiological studies of single cells in the animal brain it has been 
demonstrated that the band of spatial frequencies narrows from the retina 
to the primary visual cortex. The average bandwidth of visual cortical cells 
in cats is around 1.5 octaves (De Valois et al., 1977, 1978; Tolhurst & Thompson, 
1981) and by comparison, the average bandwidth in the lateral geniculate nucleus 
4 to 5 octaves (So & Shapley, 1981; Thibos & Levick, 1983). The average 
bandwidth of the notch defect in our two patient groups also varied according 
to the anteroposterior site of the lesion. Although the distribution of bandwidths 
for a population of neurons is rather broad, and the ischaemic lesions of the 
patients in the present study are relatively large in some cases, the narrower 
average bandwidth of the notch defects in the patient group with (temporo)-
occipital lesions (1.5 octaves) compared with the wider average bandwidth in 
patients with temporal and parietal lesions (2.5 octaves) is conspicious. 
Another issue, concerning properties of neurons subserving central visual 
function, is orientation selectivity. Orientation selectivity is a prominent attribute 
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of primary visual cortex neurons (Rubel & Wiesel, 1962), so analysis has usually 
emphasized the distribution of orientation selectivity at that level (Rubel & 
Wiesel, 1962; Mansfield, 1974; Rose & Blakemore, 1974; Mansfield & Ronner, 
1978). A particular point of interest in the present results is that they indicate 
that orientation dependent loss is not restricted to lesions of the primary visual 
cortex. Orientation bias apparently also exists in the aanterior parts of the 
postchiasmal pathway. Orientation-selective CS loss is not confined to cerebral 
infarctions. Such losses have also been reported in multiple sclerosis (Regan 
et al. 1980; Kupersmith et al., 1984) and Parkinson's disease (Regan & Maxner, 
1987; Bulens et al., 1988a) and have been explained in terms of involvement 
of cortical neurons. 
Clinicopathologic and radiographic studies have repeatedly accentuated the 
importance of the occipital striate cortex to human vision (Atensaas et al., 1974). 
Electrophysiological studies in animals have demonstrated that the cortical visual 
areas are much more comprehensive than the striate cortex (van Essen, 1979). 
In addition to the striate cortex at least 12 extrastriate areas have been 
demonstrated in the cat, and similar results have been found in primates (van 
Essen, 1979; Tusa et al., 1981). These studies also have shown the existence 
of nonoccipital areas that are involved in complex visual function. It has been 
demonstrated that there is an occipita-parieto-frontal pathway involved in spatial 
vision and an occipito-temporo-frontal pathway involved in object recognition 
(Denny Brown & Chambers 1976; Macko et al., 1982; Mishkin et al., 1983). 
Homologies between cortical areas of humans and other primates are not always 
clear, and the pattern of intercortical connections in the human brain is only 
partly understood. It is therefore difficult to compare the details of cerebral 
organization in different primates with that of man. Nevertheless, there is a 
lot of evidence that the primary visual cortex in the human has ample 
connections with surrounding association areas, the peristriate and inferotem-
poral cortex. Receptive-field properties have been extensively analysed only 
for VI in monkeys (corresponding with the striate cortex or area 17 of Brodmann 
in human). Neurons in secondary visual areas may also prove to respond 
selectively to spatial frequency and stimulus orientation. The functional columnar 
arrangement that clearly exists in VI is not yet well demonstrated beyond VI. 
Experiments showing the effects of removing a visual area on receptive-field 
properties of cells, in areas prior to VI are unknown. As monkeys in which 
VI has been totally removed can still discriminate a wide variety of patterned 
stimuli (Butter et al., 1980), the contribution to sensory analysis of pathways 
other than those from VI is presumably far from unimportant. 
Postchiasmal interference in the visual pathway produces homonymous 
hemianopia, in spite of clinically normal visual acuity. When visual field defects 
encroach upon the region of the field tested, orientation-selective CS loss may 
occur as a result of these field defects. In a simulation study Hess and Plant 
(1986) demonstrated that various types of CS loss can be modelled by different 
types of visual field loss. A deficit maximal in the centre of the visual field 
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affected high spatial frequencies, parafoveal deficit caused medium spatial 
frequency loss, and peripheral deficit gave rise to low frequency loss. Studies 
of CS across the visual field have shown that CS is maximum at the fovea 
for all spatial frequencies and falls off, monotonically at increasing eccentricities 
(Robson & Graham, 1981; Regan & Beverly, 1983; Wright & Johnston, 1983; 
Plant & Hess, 1987). Visual field defects encountered in our patient groups 
are given in Table 7. Ten of the 16 patients had homonymous hemianopia, 
nine of the 20 eyes showed normal CS function for both stimulus orientations, 
while the remaining 11 eyes showed various CS deficits ranging from low 
frequency CS loss to high frequency CS loss. Multifocal types of CS loss were 
also observed in six patients showing homonymous quadrantanopia. So, very 
different CS functions were found in patients showing similar visual field defects. 
It is therefore unlikely that uniform hemianopic involvement of the visual field 
encountered in our patient group, could be related with the observed CS losses. 
In conclusion, the results of this study attest to the hypothesis that visual 
processes are mediated by frequency selective channels (1). Orientation selectivity 
is not confined to primary visual cortex neurons, but also exists in the posterior 
visual pathway prior to the striate cortex (2). 
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Chapter IV 
SPATIAL CONTRAST SENSITIVITY 
IN PATIENTS WITH CEREBRAL TUMOURS 
INTRODUCTION 
Cerebral tumours can cause visual disturbances by various mechanisms. 
Tumours involving the visual pathway itself usually produce visual acuity losses 
or visual field defects, according to the site of the lesion. Tumours outside 
the visual pathway can also generate visual disturbances. Tumours interfering 
with CSF flow can lead to hydrocephalus or papilloedema. Ventricular distention 
may stretch fibres of the optic· pathways and may alter their function (Ehle 
& Sklar, 1979). Cerebral tumours leading to severe obstruction of CSf flow 
to the superior sagittal sinus cause papilloedema as a result of elevated CSF 
pressure (Van Crevel, 1979). All these conditions may implicate visual damage. 
Visual acuity, as measured with the Snellen letters, is often diminished in 
optic nerve disorders and may be spared or diminished in chiasmal syndromes 
(Frisen, 1980). It is a well-established clinical fact, however, that blurred vision 
without acuity impairment can occur in optic nerve dysfunction caused by 
papilloedema (Cogan, 1966; Walsh & Hoyt, 1969. The major clinical concept 
that separates papilloedema of intracranial origin from other forms of acquired 
disc swelling is that visual acuity and visual field are typically normal. Tumours 
with postchiasmal interference of the unilateral visual pathway produce he-
mianopic field defects, whereas visual acuity generally remains normal (Frisen, 
1980). Nevertheless, in spite of clinically normal acuity there may also be 
complaints of blurred vision (Bodis-Wollner & Diamond, 1976). 
Such peculiar sort of visual losses could be revealed by a more extensive 
test of central vision: determination of spatial contrast sensitivity (CS). Patients 
with cerebral tumours may exhibit a variety of visual symptoms and signs each 
of which relates to an important aspect of the underlying pathophysiology. 
In this Chapter a study is reported of spatial visual function in patients with 
cerebral tumours. The results were compared with those of conventional tests 
for visual function. 
SUBJECTS 
Control subjects 
The control population of25 subjects consisted of patients without CNS disease. 
Subjects with known astigmatism were excluded. All had ophthalmological 
examination and were free of ocular disease. Snellen acuities were 10/10 or 
better. 
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Patients 
Twenty-three patients with cerebral tumours were examined. The diagnosis 
cerebral tumour was made by CT study and in most cases (16/23) confirmed 
by neurosurgical procedures. Patients with known astigmatism were excluded. 
All had a complete neuro-ophthalmological examination including measure-
ments of corrected Snellen acuity, Goldmann perimetry, and Contrast Sensitivity. 
RESULTS 
Control group 
The mean age of the control group was 45 years (range, 26-76). The CS 
functions of the 50 control eyes were obtained and the mean CS curve is shown 
in Fig. 16. At intermediate spatial frequencies an individual curve can diverge 
slightly from the pure inverted U shape. These minor deflections occurred 
in 33 of the 50 normal eyes at different spatial frequencies (between 0.2 and 
12.8 c/d). The mean decrease factor (DF) of these minor deflections was 1.2 
(2 SD 0.2), range: 1.1 at 6.4 c/d-1.3 at 12.8 c/d, which is completely within 
intraindividual variability. 
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Figure 16. Mean contrast sensitivity curve of 50 nonnal eyes. Broken line shows 2 SD. 
Patient group (see Tables 9 & 10) 
The mean age of the 23 patients was 48 years (range, 26-78). Seven patients 
had bilateral papilloedema in association with a cerebral tumour. Sixteen patients 
had a cerebral tumour but normal fundus appearance. 
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The CS function of each of the patient's eyes was individually compared 
with the mean CS curve of the controls. A curve was judged abnormal when 
a CS deficit resulted in a displacement of (a part of) the curve below the control 
curve for more than 2 SDs. Selective frequency loss was taken for abnormal 
(notch defect) when the DF was more than 1.4, being the mean DF in the 
normal group plus 2 SDs. The width of the notch was defined as the spatial 
frequency bandwidth over which contrast loss was observed (octaves). 
Table 9. 23 patients with cerebral tumours 
16 patients without 
papilloedema 
7 patients with 
papilloedema 
5 patients: no direct or indirect 
involvement visual pathway 
7 patients: direct involvement visual 
pathway 
4 patients: hydrocephalus 
3 patients: cerebello-pontile 
tumour 
4 patients: direct involvement 
visual pathway 
(I) Patients with cerebral tumours and no papilloedema 
CS normal 
(10/10) 
Notch loss 
(9/14) 
2 no Occipital 
distention: 
CS normal 
(4/4) 
2 Occipital 
distention: 
CS abnormal 
(4/4) 
Notch loss 
(6/6) 
Various types 
ofCS loss 
(8/8) 
Five of the 16 patients in this group (no. 1-5) had cerebral tumours without 
direct or indirect involvement of the visual pathway. They had normal visual 
acuities and visual fields. All I 0 CS functions were normal. 
Seven patients (no. 6-12) had cerebral tumours with direct interference of 
the unilateral visual pathway. Visual acuities were 10/10 or better. All showed 
visual field defects according to the site of the lesion. Nine of the 14 eyes 
showed CS losses, all notch defects (range, 0.2-3.2 c/ d). Four notch losses resulted 
from an occipital lesion (3 patients). The mean bandwidth was 2.8 octaves 
(range, 2-3), with a mean depth of 1.5 (2 SD 0.1). The three notch defects 
which occurred in two patients with (occipita-) parietal lesions had a mean 
bandwidth of 1.8 octaves (range, 1.5-2) and a mean depth of 1.5 (2 SD 0.2). 
Two patients with a lesion of the temporal genu of the optic radiation had 
notch defects of two and four octaves wide and 1.6 and 2.1 deep (DF). All 
notches occurred in the low spatial frequency range (below 3.2 c/ d) (Table 
10). 
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Table 10. Clinical data and results of neuro-ophthalmological examination in 23 patients with 
cerebral tumours. 
No. Age Sex Diagnosis Visual field Snellen cs 
acuity function 
(I) PATIENTS WITH CEREBRAL TUMOURS AND NO PAPILlDEDEMA 
21 m Suprasellar Intact R 15/10 normal 
tumour L 15/10 normal 
2 25 m R Cerebella- Intact R 15/10 normal 
pontile tumour L 15/10 normal 
3 32 m R Parieto- Intact R 13/10 normal 
temporal glioma L 12/10 normal 
4 55 f R Parietal Intact R 12/10 normal 
Meningioma L 12/10 normal 
5 78 m R Frontal Intact R 10/10 normal 
Metastasis L 10/10 normal 
6 30 m L Occipital •R homonymous R 10/10 notch loss (0.4-3.2) 
Metastasis hemianopia L 12/10 notch loss (0.4-3.2) 
7 55 f R Temporal L homonymous R 15/10 notch loss (0.8-3.2) 
Glioma quadrantoanopia L 15/10 notch loss (0.8-3.2) 
8 57 m R Occipital L homonymous R 10/10 normal 
Metastasis hemianopia L 13/10 notch loss (0.2-1.6) 
9 57 f L Parietal R homonymous R 10/10 normal 
Metastasis hemianopia L 10/10 notch loss (0.8-2.4) 
10 62 m L Optic radiation R homonymous R 10/10 notch loss (0.2-3.2) 
Metastasis quandrantoanopia L 12/10 normal 
ll 66 f R Optic radiation L homonymous R 12/10 normal 
Metastasis quadrantoanopia L 12/10 notch loss (0.4-1.6) 
12 70 f R Occipital L homonymous R 10/10 normal 
Meningioma hemianopia L 10/10 notch loss (0.4-1.6) 
13 36 f Colloid cyst Intact R 15/10. normal 
third ventricle L 15/10 normal 
14 40 m Colloid cyst Intact R 10/10 normal 
third ventricle L 10/10 normal 
15 55 f R Cerebellair Intact R 12/10 notch loss (0.4-1.6) 
Metastasis L 12/10 notch loss (0.2-0.8) 
16 58 f R Cerebellair Intact R 10/10 h loss 
Metastasis L 10/10 notch loss (0.4-1.6) 
Four patients (no. 13-16) had obstructive hydrocephalus. Two patients had 
a cerebellar tumour and two others a colloid cyst of the third ventricle. Visual 
acuity scores and visual fields were normal. Both patients with obstruction of 
the fourth ventricle and distention of the occipital horns of the ventricle system 
had abnormal CS functions. One patient had high frequency loss in one eye 
and a notch loss of two octaves wide centered at 0.8 c/ d in the other eye. 
The other patient had a notch loss of two octaves wide in both eyes in the 
low frequency range (0.2-1.6 c/ d). The two patients with a colloid cyst of the 
third ventricle and no involvement of the occipital horns, had normal CS 
functions in all four eyes. 
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Table 10 continued 
No. Age Sex Diagnosis Visual field Snellen cs 
acuity function 
(II) PATIENTS WITH CEREBRAL TIJMOURS AND PAPILI.DEDEMA 
17 26 m L Parieto- Enlarged blind R 6/10 h loss 
temporal glioma spots L 8/10 h loss & notch loss 
(0.2-0.8) 
18 33 m L Cerebello- Enlarged blind R 15/10 notch loss (0.4-1.6) 
pontile tumour spots L 15/10 notch loss (0.8-3.2) 
19 33 f Suprasellar Bitemporal hemi- R 9/10 h loss 
tumor anopia & enlarged L 7/10 generalized loss 
blind spots 
20 43 m R parietotemporal Enlarged blind R 7/10 h loss 
metastasis spots L 6/10 h loss 
21 54 f R Cerebello- Enlarged blind R 15/10 notch loss (0.8-3.2) 
pontile tumour spots L 10/10 notch loss (0.8-3.2) 
22 55 m R Parietal L homonymous R 3/10 generalized & notch 
Meningioma hemianopia loss (0.4-1.2) 
L 3/10 generalized & notch 
loss (0.2-0.8) 
23 56 f L Cerebello- Enlarged blind R 15/10 notch loss (0.8-3.2) 
pontile tumour spots L 15/10 notch loss (0.8-3.2) 
Key to symbols as in table 4. 
(II) Patients with cerebral tumours and papilloedema 
All seven patients in this group (no. 17-23) had abnormal CS function in 
both eyes. 
Three patients with a cerebellopontile angle tumour without direct effect 
on the visual pathway had normal visual acuities and only enlarged blind spots 
on visual field examination. The only type of CS deficit observed in all six 
eyes was a notch defect. The width of these six notches was two octaves and 
the mean depth (DF) 1.9 (2 SD 0.6). Five of the six notches were centered 
at 1.6 c/ d, the other at 0.8 c/ d. 
The other four patients with papilloedema had tumours that directly interfered 
with the visual pathway. These four patients had visual acuity impairments 
and visual field defects in both eyes. They showed diverse types of CS loss: 
four eyes had high frequency CS loss, one eye high frequency CS and notch 
CS loss, one eye generalized CS loss and two other eyes a combination of 
generalized and notch CS loss. One notch with a depth of 3.5 (DF) and two 
octaves wide was centered at 0.8 c/ d and the two other notches with a depth 
of 1.9 (DF) and also two octaves wide were centered at 0.4 c/ d. 
Clinical data and the results of neuro-ophthalmological examination in all 
patients are shown in Table 10. Examples of abnormal CS function in six patients 
are given in Fig. 17. 
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Figure 17. Examples of contrast sensitivity curves in six patients with a cerebral tumour. The upper 
part of each figure shows the ratio of the altered contrast sensitivity to normal contrast sensitivity 
function for corresponding spatial frequencies (visuogram). 
Right eye = ~pen circles and Left eye = closed circles. 
(A) Case 6 (L Occipital metastasis) shows n loss (0.4-3.2) in both eyes. 
(B) Case 11 (R Optic radiation metastasis shows n loss (0.4-3.2) in right eye and normal CS curve 
in left eye. 
(C) Case 16 (Obstructive hydrocephalus) shows h loss in right eye and n loss (0.4-L6) in left 
eye. 
(D) Case 18 (L Cerebello-pontile tumour, bilateral papilloedema) shows n loss (0.4-L6) in right 
eye, and n loss (0.8-3.2) in left eye. 
Figure 17 continued 
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(E) Case 22 (R Parietal Meningioma, bilateral papilloedema and impaired visual acuities) shows 
generalized & n loss (OA-L2) in right eye and generalized & n loss (0.2-0.8) in left eye. 
(F) Case 23 (L Cerebello-pontile tumour, bilateral papilloedema) shows n loss (0.8-3.2) in both 
eyes. 
(L = left, R = right, n loss = notch contrast sensitivity loss, h loss = high frequency contrast 
sensitivity loss; spatial frequency range in cycles/ degree. 
DISCUSSION 
Cerebral tumours may produce various visual symptoms and signs. Tumours 
involving the visual pathway itself usually account for visual acuity impairment 
or field defects. Tumours without direct effect on the visual pathway, but 
interfering with CSF flow (papilloedema, hydrocephalus), can also exhibit visual 
damage. A diagram to show the possible mechanisms leading to visual damage 
is shown in Fig. 18. The present findings showed that there is no distinctive 
correspondence of visual acuity and field charting to CS. 
Eighteen of our group of 23 patients with cerebral tumours had direct or 
indirect involvement (including papilloedema) of the visual pathway. Spatial 
CS function was abnormal in 27 of the 36 eyes (75%). The remaining group 
of five patients without direct or indirect interference of the visual pathway 
had, not surprisingly, normal CS function for both eyes. Of the 27 eyes with 
abnormal CS function only eight had also visual acuity loss. All eyes with 
impairment of visual acuity showed high frequency or generalized CS loss. 
CS measurement was therefore, superior in comparison to Snellen acuity testing 
by revealing visual disturbances in patients with cerebral tumours. 
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Figure 18. Diagram showing the possible mechanisms leading to visual damage. 
(A) Seven patients with tumours that directly interfered with the visual pathway 
and no papilloedema had hemianopic field defects but normal Snellen acuity 
scores. The only type of CS deficit, observed in nine of the 14 eyes, was a 
notch defect, selectively affecting the low spatial frequency range. The mean 
bandwidth of the notches in patients witp occipital lesions was 2.8 octaves wide 
and in patients with (parieto-)temporal lesions 1.8 octaves. Two of the four 
patients with obstructive hydrocephalus showed abnormal CS functions. These 
patients both had distention of the occipital horns of the ventricular system. 
(B) Of the seven patients with papilloedema three had a tumour outside 
the visual pathway and papilloederoa as a result of elevated CSF pressure was 
the only neuro-ophthalmological sign. All six eyes showed notch defects of 
two octaves wide affecting the low spatial frequency range. Five of the six 
notches were centered at 1.6 c/ d. These patients had preservation of Snellen 
acuity and only enlarged blind spots on visual field examination. The four 
patients with papilloedema and impaired visual acuity had tumours compro-
mising the visual pathway and showed generalized- and high spatial frequency 
CS loss. 
The present data confirm earlier reports of abnormal CS function in patients 
with cerebral tumours. Bodis-Wollner and Diamond (1976) using methods similar 
to those described in this study, found impairment of CS in 35 patients with 
cerebral lesions of heterogeneous aetiology. Seventeen of these had a cerebral 
tumour. High frequency loss was established in six patients, generalized loss 
in another six patients and a notch loss in five patients. Six of the 12 patients 
with high frequency or generalized CS loss, however, had normal Snellen 
acuities, and only one of the five patients with a notch defect had unimpaired 
61 
visual acuity. Kupersmith et al. (1981) found a reduction in CS in 80 of the 
85 eyes with proved chiasmal compression. These workers used Arden's grating 
plates (1978) to measure CS. With this method high spatial frequencies (above 
6.4 c/ d) cannot be tested; CS loss was observed at all spatial frequencies 
(generalized loss), even in patients with normal Snellen acuities. 
According to the theory of pattem recognition, it has been proposed that 
visual input is processed via spatial frequency channels of unequal sensitivity 
(Enroth-Cugell & Robson, 1966; Campbell & Robson, 1968; Campbell et al., 
1969; Blakemore & Campbell, 1969; Albrecht et al., 1980; Regan, 1982). Spatial 
frequency selectivity is mainly attributed to cortical neurons and not, or only 
to a less degree to neurons of the retina or geniculate body (Campbell & Robson, 
1968; Regan, 1982). Neurophysiological work on the spatial frequency tuning 
of cortical neurons is of particular significance because of its relevance to 
the idea that the human visual system contains highly tuned channels or spatial 
frequency filters (Campbell & Robson, 1968; Blakemore & Campbell, 1969; 
Graham, 1977). The degree of spatial tuning may be quantified by calculating 
the spatial frequency bandwidth over which contrast loss is observed. Several 
investigators have established that individual striate cortex neurons have narrow 
bandwidths, but also a broad distribution of optimal spatial frequencies. 
Depending on the type of experiment different workers found that the visual 
pathway contains spatial frequency channels of one to four octaves wide 
(Blakemore & Campbell, 1969; Spitzberg & Richards, 1975). 
In this study seven patients had a cerebral tumour with direct involvement 
of the visual pathway and no papilloedema. The only type of CS deficit observed, 
was a notch loss in the low spatial frequency range, which occurred in nine 
of the 14 eyes. If we assume that the notch defects represent a partial or complete 
loss of one or more channels sensitive to a restricted range of spatial frequencies, 
our finding that cerebral tumours confined to the visual pathway can selectively 
reduce CS in the low spatial frequency range, can be taken as further evidence 
for the existence of such channels. The frequency-selective CS losses, generated 
by patients with normal Snellen acuities, establishes that cerebral lesions may 
produce a disruption of a limited number of frequency channels subserving 
central vision. Though the present results are unsuitable for statistical analysis, 
the notch losses with a wider bandwidth in patients with occipital lesions 
compared to the narrower bandwidth in patients with (occipito-)parietallesions 
are of interest. They might indicate that the degree of spatial tuning at different 
sites of the visual system can be studied under pathological conditions. 
Two of the four patients with obstructive hydrocephalus had abnormal CS 
functions, both had obstruction of the fourth ventricle and distention of the 
occipital homs. The localization of the disruption of the visual pathways that 
causes these CS losses is less certain. Because of the long pathway, and its 
close relationship to the ventricular system, compromise of the optic radiations 
could be responsible in part for the CS abnormalities. Direct effects on the 
occipital cortex could also account for the CS losses. Both patients with CS 
62 
deficits demonstrated a prominent distention of the occipital horns of the 
ventricular system. 
In three of the seven patients with papilloedema there was no direct 
involvement of the visual pathway and bilateral papilloedema was the only 
neuro-ophthalmological sign. The six notch defects in these patients were all 
two octaves wide, while five of the six deficits were centered at the 6,4 c/ d 
spatial frequency. The notch defects in these patients did not differ from 
the patterns of CS loss in patients with direct involvement of the visual pathway 
and normal Snellen acuities. It is difficult to specifY how similar frequency-
selective deficits arise in patients with papilloedema, because such losses are 
mainly attributed to involvement of the cortical visual neurons. Apparently 
peripheral damage can also in some degree degrade spatial processing. In 
animal studies, spatial frequency selectivity has also been demonstrated in 
neurons of the retina and lateral geniculate body. It has been suggested that 
the retinal image is encoded by the ratio of activity in neuronal populations 
responsive to different spatial frequencies (Pollen et al., 1971; Maffei & Fiorentini, 
1973). In papilloedema, neural deficit may decrease spatial processing and result 
in frequency-selective CS losses, closely resembling CS losses of post-chiasmal 
lesions. 
When field defects encroach upon the region of the field tested, CS loss 
may occur as a result of these field defects. In a simulation study Hess and 
Plant (1986) demonstrated that various types of CS loss can be modelled by 
different types visual field loss. Visual field defects encountered in our patient 
group are given in Table 10~ Patients with similar field defects had markedly 
different CS deficits. Moreover, patients with unilateral CS deficits had hom-
onymous hemianopia and quadrantanopia on visual field charting. It is therefore 
unlikely that involvement of the visual field encountered in our patient group, 
could be related with the observed CS losses. 
Although the results of our study are by no means conclusive, they attest 
to the hypothesis that visual processes are mediated by frequency-selective 
channels. Functional disruption or anatomical lesions of the visual pathway 
can selectively damage some frequency-selective channels, while the others 
continue to function normally. Spatial frequency-selective CS losses. can result 
from lesions involving the visual pathway from optic radiation to primary visual 
cortex. Even tumours without direct involvement of the posterior visual pathway 
(papilloedema, hydrocephalus) can cause frequency-selective CS loss. 
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ChapterV 
CONTRAST SENSITM1Y IN PATIENTS WITH 
BENIGN INTRACRANIAL HYPERTENSION 
INTRODUCTION 
In Benign Intracranial Hypertension (BIH), loss of visual acuity is the only 
serious complication, and may occur either early or late in its course (Corbett 
et al., 1982). Regular ophthalmological examination, including assessment of 
the visual fields, is mandatory. A major problem, however, is that there is no 
reliable warning sign of impending visual failure, which obstructs rational 
decision in treatment (Bulens et al., 1979). Patients with papilloedema from 
whatever cause - tumour or benign intracranial hypertension - may present 
with obscurations or blurred vision (Cogan, 1966; Walsh & Hoyt, 1969; Boddie 
et al., 1974; Johnston & Paterson, 1974; Weisberg, 1975; Bulens et al., 1979; 
Rush, 1980; Corbett et al., 1982; Orcutt et al., 1984). Optic nerve dysfunction 
caused by papilloedema can decrease central visual function, in spite of clinically 
normal visual acuity. 
Subtle visual deficits may not be detected using routine tests, such as Snellen 
acuity scores, visual field estimation, or colour vision testing. Such patients might 
have a peculiar sort of visual disturbance, reducing central visual function, 
without affecting visual acuity. For evaluating spatial vision, sensitivity measu-
rements to visual contrast using stimuli ranging from low spatial frequencies 
(coarse patterns) to high spatial frequencies (fine patterns) can be determined. 
In the present study we investigated the effect of BIH on CS function. 
SUBJECTS 
The control population of 20 subjects consisted of hospital personnel and 
patients without CNS disease. All had neuro-ophthalmological examination and 
were free of ocular disease. Snellen acuities were 10/10 or better. 
Twenty patients were studied who complied with the definition ofBIH: syptoms 
and signs of raised CSF pressure including papilloedema, without a space-
occupying lesion, normal CSF under raised pressure, and normal ventricular 
size on CT-scan. All had a complete neuro-ophthalmological examination which 
included measurements of corrected Snellen acuity, Goldmann perimetry, and 
Contrast Sensitivity. 
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RESULTS 
Control group 
The mean age of the control group was 40 years (range, 26-59). The CS 
functions of the 40 control eyes were obtained and the mean CS curve is shown 
in Fig. 19. Close inspection of individual CS curves in normal subjects can 
reveal that at intermediate spatial frequencies a CS curve can diverge slightly 
from the pure inverted U shape (Fig. 19). These minor deflections occurred 
in 27 of the 40 normal eyes at different spatial frequencies (between 0.2 and 
12.8 c/d). The mean decrease factor (DF) of these minor deflections was 1.2 
(2 SD 0.2), range: 1.1 at 6.4 c/d- 1.3 at 12.8 c/d, which is completely within 
intraindividual variability. 
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Figure 19. Mean contrast sensitivity curve in 20 normal subjects. Broken line shows 2 SD. 
Patients 
The mean age of the 20 BIH patients was 39 years (range, 16-59). There 
were 16 females and four males. Eleven patients were obese and systemic 
hypertension (BP of 170/95 or higher) was present in four. Papilloedema, the 
cardinal feature, was present in all patients and was confirmed by fluorescein 
angiography in eight cases. Neuroradiological investigations (skull radiographs 
and CT scans) revealed that two patients had an empty sella. Carotid angiography, 
carried out in four males and two females, was normal in all. The increased 
CSF pressure ranged from 30 to 60 em water (lumbar puncture). 
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Impairment of visual acuity was defined as Snellen acuity of less than 10/10. 
Nine patients had impairment of visual acuity (9 eyes). In three of these (patient 
3, 7, 19) the poor visual acuity was unrelated to BIH (unilateral amblyopia 
since childhood). Five patients had mild impairment (7 /10 or more), one patient 
had a marked degree of impairment of vision (3/10). 
Visual fields were assessed by Goldmann perimetry in all patients. Only four 
showed abnormalities other than enlarged blind spots. One patient had severe 
concentric constrictions in both eyes. Another patient had a cecocentral scotoma 
with impaired visual acuity in one eye and a normal visual field with unimpaired 
visual acuity in the other. One patient had inferior binasal field defects with 
unilateral acuity loss. The fourth patient had an unilateral inferior nasal field 
defect and normal acuity in both eyes. 
The contrast sensitivity function of each ofthe patient's eyes was individually 
compared with the mean CS curve of the controls. A curve was judged abnormal 
when a CS deficit resulted in a displacement of (a part of) the curve below 
the control curve minus two standard deviations. Intermediate frequency loss 
was considered abnormal (notch defect) when the decrease factor (DF) was 
more than 1.4, being the mean DF in 27 of the 40 normal eyes plus two standard 
deviations. The width of the notch was defined as the spatial frequency 
bandwidth over which contrast loss was observed (octaves). CS function was 
obtained in 40 eyes. Of the 37 non-amblyopic eyes 16 had abnormal CS function. 
Generalized loss was seen in three eyes. Losses that could be classified as 
frequency selective were found in 13 eyes. Of these 13 eyes a notch loss was 
present in eight eyes. The loss affected selectively the high frequency range 
(above 3.2 c/ d) in three eyes and the low frequency range (below 3.2 c/ d) 
in two eyes. 
Abnormalities of CS function were not related to visual acuity loss. Of the 
37 non-amblyopic eyes 16 had CS loss (43%). Twelve of these 16 eyes had 
normal visual acuities. Six of the eight eyes with notch defects had a normal 
vision. Of the three eyes with high frequency loss two had normal visual acuities, 
and of the two eyes with low frequency loss none had acuity loss attributed 
to BIH. Two of the three eyes with generalized loss had normal visual acuities. 
Two of the three patients with impaired acuity not related to BIH (amblyopia) 
showed CS loss. One patient had low frequency loss with a vision of 7/10, 
and the other showed high frequency loss with a visual acuity of 1/10. The 
third patient with unilateral amblyopia (acuity 9/10) had a normal CS curve 
of the affected eye. 
Six eyes (16%) had acuity impairment at presentation, attributed to BIH. Only 
two eyes with slight acuity impairment (9/10) had normal CS functions. The 
remaining four eyes with acuity impairment had diverse types of CS loss 
(generalized-, notch- and high-frequency loss). 
Transient visual obscurations were an initial symptom in four patients. Three 
of these had unilateral visual acuity impairment at presentation. Blurred vision 
with normal visual acuity was an initial complaint in five patients. All these 
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nine patients had abnormal CS functions (12 eyes). The results of neuro-
ophthalmological investigations of all 20 patients are listed in Table 11. 
Table 11. Results at presentation of neuro-ophthalmological investigations in 20 BIH patients. 
No. Sex Age Vision Snellen Pap ill- Visual field CS function 
acuity oedema 
F 16 Blurred R 11110 2 Enl. blind spot no loss 
L 10/10 2 Enl. blind spot n loss (0.4-3.2) 
2 F 17 Blurred R 15/10 2 Enl. blind spot n loss (0.8-2.4) 
L 10/10 2 Enl. blind spot no loss 
3 F 24 Normal R 9/10 2 Enl. blind spot no loss 
(amblyopic) 
L 10/10 1 Enl. blind spot no loss 
4 F 33 Obscurations R 12/10 2 Enl. blind spot n loss (3.2-12.8) 
L 15/10 1 Enl. blind spot n loss (0.4-1.6) 
5 F 34 Blurred R 10/10 1 Severe concentric lloss 
constriction 
L 10/10 Severe concentric lloss 
constriction 
6 M 34 Normal R 15/10 Enl. blind spot no loss 
L 15/10 Enl. blind spot no loss 
7 F 37 Blurred R 13/10 Enl. blind spot generalized loss 
L 7/10 Normal 1loss 
(amblyopic) 
8 F 40 Blurred R 10/10 1 Enl. blind spot generalized loss 
L 3/10 1 Enl. blind spot generalized loss 
9 F 40 Blurred R 10/10 1 Enl. blind spot no loss 
L 10/10 2 Enl. blind spot n loss (0.2-0.8) 
10 F 41 Normal R 10/10 1 Enl. blind spot no loss 
L 10/10 1 Enl. blind spot no loss 
ll F 41 Normal R 10/10 2 Enl. blind spot no loss 
L 10/10 1 Enl. blind spot no loss 
12 F 42 Blurred R 10/10 2 Enl. blind spot n loss (0.8-6.4) 
L 10/10 2 Enl. blind spot no loss 
13 M 43 Obscurations R 10/10 1 Normal no loss 
L 7/10 2 Cecocentral n loss (1.6-6.4) 
scotoma 
14 F 46 Normal R 11110 1 Enl. blind spot no loss 
L 9/10 1 Enl. blind spot no loss 
15 F 47 Normal R 12/10 1 Normal no loss 
L 12/10 1 Nasal defect no loss 
16 F 49 Obscurations R 10/10 1 Enl. blind spot no loss 
& nasal defect 
L 8/10 Enl. blind spot n loss (0.8-3.2) 
& nasal defect 
17 F 51 Obscurations R 11110 1 Enl. blind spot h loss 
L 8/10 2 Enl. blind spot h loss 
18 F 55 Normal R 9/10 2 Enl. blind spot no loss 
L 10/10 1 Enl. blind spot no loss 
19 M 57 Normal R 10/10 1 Enl. blind spot no loss 
L 1110 1 Enl. blind spot h loss 
(amblyopic) 
20 M 59 Normal R 12/10 2 Enl. blind spot no loss 
L 10/10 2 Enl. blind spot h loss 
Key to symbols as in table 4 
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Eleven patients had repeated CS measurements after one to 60 months. The 
results of the follow-up investigations of these 11 patients are listed in Table 12. 
Table 12. Follow-up results of neuro-ophthalmological investigations in 11 BIH patients 
Results at presentation Results at follow-up 
No. Snellen CS function Treatment Follow-up Snellen CS function Comment 
acuity (months) acuity 
2 R 15/10 n loss (0.8-2.4) none R 15/10 no loss normal fundi 
L 10/10 no loss L 10/10 no loss & fields 
3 R 9/10 no loss diuretics 60 R 9/10 h loss amblyopia R; 
L 10/10 no loss L 10/10 h loss chronic oedema 
normal fields 
6 R 15/10 no loss none 8 R 15/10 no loss normal fundi 
L 15/10 no loss L 15/10 no loss & fields 
7 R 13/10 generalized weight 29 R 13/10 h loss normal fundi 
loss reduction & fields 
L 7/10 !loss L 7/10 no loss amblyopia L; 
8 R 10/10 generalized weight 20 R 10/10 !loss normal fundi 
loss reduction & fields 
L 3/10 generalized L 3/10 generalized 
loss loss 
11 R 10/10 no loss weight 3 R 10/10 no loss normal fundi 
L 10/10 no loss reduction L 10/10 no loss & fields 
12 R 10/10 n loss (0.8-6.4) none 3 R 10/10 no loss subsiding 
oedema, en!. 
L 10/10 no loss L 10/10 no loss blind spots 
13 R 10/10 no loss lumbar 3 R 10/10 no loss normal fundi 
L 7/10 n loss (1.6-6.4) peritoneal L 11110 no loss & fields 
shunt 
15 R 12/10 no loss none 18 R 12/10 generalized chronic oedema 
& n loss optic atrophy 
(0.4-1.6) R&L 
L 12/10 no Joss L 12/10 generalized 
loss 
16 R 10/10 no loss none 6 R 12/10 no loss normal fundi 
L 8/10 n loss (0.8-3.2) L 10/10 no loss & fields 
18 R 9/10 no loss none 8 R 9/10 n loss chronic oedema 
(0.8-3.2) en!. blind 
L 10/10 no loss L 10/10 no loss spots 
Key to symbols as in table 4 
Six patients had a normal CS function for both eyes at follow-up, they all 
had restored visual acuities. Fig. 20A. shows the changes of serially CS me-
asurements in patient no. 2. Initially there was un unilateral notch loss centered 
at 1.6 c/d (right eye). Two weeks later notch losses centered at the same spatial 
frequency were observed in both eyes. Another two weeks later, after pa-
pilloedema had disappeared, CS losses had completely resolved. Of this group 
of patients with normal CS function at follow-up, one had developed optic 
disc pallor and another still had subsiding papilloedema in spite of normal 
1000 
100 
10 
1000 
100 
10 
0.1 
. .;, 
i ( 
0 
0.1 
PATIENT 2 
LEFT EYE 
10 
SPATIAL FREQUENCY C/degree 
p 
PAT!ENT 7 
LEFT EYE 
.0-. 
c····· ···o. 
.o···· 
b 
10 
SPATIAL FREQUENCY C/degree 
68 
100 
10 
100 0.1 
1000 
100 
10 
100 0.1 
PATIENT 2 
RIGHT EYE 
I 
'·.\ 
\ 
\ 
10 
SPATIAL FAEOUENC'I' C/degree 
PATIENT 7 
RIGHT EYE 
10 
SPATIAL FREQUENCY C/degree 
Figure 20. Examples of serial contrast sensitivity (CS) measurements in 4 patients. 
100 
100 
(A) Patient 2 had a unilateral notch loss Gt!ntered at 1.6 c/d (right eye) at presentation (filled 
circles), 2 weeks later notch losses centered at 1.6 c/ d in both eyes (open circles-broken lines) 
and complete resolution of the CS losses after 4 weeks (open circles-dotted lines). 
(B) Patient 7 showed initially generalized CS loss (right eye) and I loss (left eye) (filled circles) 
with good improvement after 29 months except for h loss in the right eye (open circles). 
acmtles. Five patients had abnormal CS functions. One patient (no. 3) had 
developed high frequency loss in both eyes without visual acuity deterioration. 
She had bilateral papilloedema of one dioptre for 60 months. Patient no. 7 
(Fig. 20B) had good improvement of CS function for both eyes except for 
high frequency loss in the right eye. During her illness of three years, visual 
acuity scores had not changed and her visual fields had become normaL Patient 
no. 8 (Fig. 20C) had persisting general CS loss in the left eye with marked 
degree of acuity loss (3/1 0), which was unchanged after 20 months. CS function 
of the right eye had ameliorated and only low frequency loss was present at 
follow-up. Patient no. 15 (Fig. 20D) illustrates progressive CS loss for both eyes 
Figure 20 continued 
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(C) Patient 8 had generalized CS loss in both eyes at presentation (filled circles) with recovery 
in the high spatial frequency range (right eye) and unchanged CS curve in the left eye (open 
circles) after 20 months. 
(D) Patient 15 had initially normal CS curves (filled circles) and progressive CS loss at follow-
up without any change of acuity scores, after 12 months notch loss centered at 0.8 c/d and h 
loss (right eye), generalized loss (left eye) (open circles-broken lines); after 18 months generalized 
CS loss and n loss at 0.8 c/d (right eye), generalized Joss in left eye (open circles-dotted lines). 
during 18 months follow-up without any change of visual acmues or visual 
fields. Patient no. 18 with normal CS functions and unilateral acuity impairment 
developed a notch defect without any acuity deterioration. 
DISCUSSION 
Spatial CS function, in 20 BIH patients, elicited by sinewave gratings, was 
abnormal in 16 of the 37 non-amblyopic eyes. Six eyes had Snellen acuity 
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impairment attributed to BIH. Only four of the 16 eyes with abnormal CS 
function had also acuity loss. Only two eyes with slight visual acuity impairment 
attributed to BIH had normal CS function. In one of these two, a notch defect 
later developed during follow-up, without deterioration of visual acuity. CS 
measurement was, therefore, superior in detecting visual loss in comparison 
with the Snellen acuity tests. 
Our data confirm one earlier report of abnormal visuospatial CS function 
in BIH. Wall (1986) found CS loss in 13 of 24 eyes of BIH patients. His results 
were based on the Arden grating test (Arden, 1978). 
Visual obscurations and blurred vision are the most frequent visual symptoms 
in BIH (Boddie et al., 1974;Johnston & Paterson, 1974; Weisberg, 1975; Bulens 
et al., 1979; Rush, 1980; Corbett et al., 1982; Orcutt et al., 1984). In this study 
there was a close relationship between the presence of these visual symptoms 
and CS abnormality. All 11 patients with blurred vision or visual obscurations 
had abnormal CS functions. Six of·these 11 patients had normal visual acuities 
at presentation. Seven of the nine patients with normal subjective vision had 
also normal CS curves for both eyes. One patient had unilateral high frequency 
CS loss with normal visual acuity and another patient had also high frequency 
CS loss in one eye with impaired visual acuity due to amblyopia since childhood. 
The CS loss of this patient probably was not related to BIH. 
Although there was no unitary type of CS loss in our patient group, the 
most frequent type of deficit, observed in eight eyes, was a notch defect. These 
intermediate spatial frequency losses affected the middle-frequency region 
preferentially. These CS losses are not unique to papilloedema. Results similar 
to those described here, have also been reported in conditions ranging from 
optic neuritis (Zimmern et al., 1979; Medjbeur & Tulunay-Keesy, 1985) and 
cortical lesions (Bodis-Wollner & Diamond, 1976; Bulens et al., 1988b) to 
Parkinson's disease (Regan & Maxner, 1987; Bulens et al., 1988a). Spatial 
frequency selectivity is attributed to cortical neurons and not, or only in a 
less degree to neurons of the retina or geniculate body (Campbell & Robson, 
1968; Regan, 1982). Peripheral damage, however, can also in some degree 
selectively degrade CS. It has been suggested that the retinal image is encoded 
by the ratio of activity in neuronal populations responsive to different spatial 
frequencies (Pollen et al., 1971; Maffei & Fiorentini, 1973). A neural deficit 
that distorts the sensitivity of these harmonic analysers may impair spatial 
processing. Sinewave gratings effectively stimulate populations of neurons 
responsive to only limited bands of spatial frequency. In papilloedema, neural 
deficit may result in depression of CS restricted to intermediate spatial fre-
quencies. 
When field defects and enlarged blind spots encroach upon the region of 
the field tested, CS loss may occur as a result of these field defects. In a simulation 
study Hess and Plant (1986) demonstrated that various types of CS loss can 
be modelled by different types of visual field loss. A deficit maximal in the 
centre of the visual field affected high spatial frequencies, parafoveal dificit 
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caused medium spatial frequency loss, and peripheral deficit gave rise to low 
frequency loss. Visual field defects encountered in our patient group are given 
in Table 11. An enlarged blind spot is the classic defect in BIH and was detected 
in 31 non-amblyopic eyes of 17 patients either as the only visual defect or 
associated with other disc-related defects. The stimulus field subtended the 
enlarged blind spots only when CS was measured for low spatial frequencies. 
For higher spatial frequencies (0.8 to 25.6 c/ d) the enlarged blind spot did 
not encroach upon the field tested, bound with the relative small stimulus field 
at 200 em (8.5 degrees by 6.0 degrees). The generalized losses (3 eyes), high 
frequency losses (3 eyes) and notch defects in the frequency range above 0.8 
c/d (4 eyes) could therefore not have been accounted for by the enlarged 
blind spot. Some effect of the enlarged blind spot in generating the intermediate 
spatial frequency losses below 0.8 c/d (3 eyes) cannot be excluded. Two of 
the three eyes showing nasal field defects, had normal CS function; the remaining 
eye had a two octaves wide CS loss centered at 1.6 c/d. Only one patient (no. 5) 
had marked field defects. It is well known that the thresholds for gratings 
are significantly raised ifless than four cycles of the gratings are visible (Campbell 
& Robson, 1968; Savoy & McCann, 1975; Van der Wildt et al., 1976). In this 
patient the low frequency CS loss in both eyes, could be considered therefore, 
as a result of the severe concentric field constriction. It seemed unlikely that 
the cecocentral scotoma in the left eye of patient no. 13 could account for 
the two octaves wide notch loss centered at 3.2 c/ d, because CS for higher 
spatial frequencies were unaffected. The vast majority of CS deficits encountered 
in our patient group could not be explained by the visual field abnormalities. 
The clinical application of CS measurement in monitoring the progression 
or regression of BIH is well illustrated by the serial measurements in 11 patients 
with BIH. Progressive visual loss in longstanding papilloedema and important 
improvement of visual function in subsiding papilloedema can occur without 
any change in Snellen acuity or visual field charting. In our limited follow-
up study important visual acuity deterioration was not observed, even progressive 
CS loss did not predict subsequent visual acuity loss. 
Although some factors as systemic hypertension, raised intraocular pressure, 
choroidal folds with subretinal neovascularisation may predispose to severe 
loss of acuity (Corbett et al., 1982; Orcutt et al., 1984), general outcome in 
BIH cannot be predicted reliably. Visual acuity loss can occur at presentation 
or late during the course of the disease. Blurred vision and visual obscurations 
do not necessarily predict subsequent visual acuity loss. Visual field abnormalities, 
including nasal field defects and concentric constrictions have not proved to 
determine long-term prognosis for visual acuity. Even optic atrophy is not always 
accompanied by acuity loss or field defects. A more extensive, prospective study 
of BIH with sequential measurements of CS, visual fields and Visual Evoked 
Potentials is warranted to reliably demonstrate warning signs of impending 
visual failure. 
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Chapter VI 
GENERAL DISCUSSION 
In the previous chapters the application of contrast sensitivity (CS) measu-
rements in· clinical neurology has been described. The investigations in normal 
subjects and patients with various neurological disorders have demonstrated 
the importance of this psychophysical method for studying visual function. 
Based on psychophysical experiments, Campbell and Robson (1968) proposed 
that there might be functionally separate mechanisms (channels) in the visual 
nervous system, selectively responding to different spatial frequencies. Although 
this channel hypothesis is not universally held, spatial frequency analysis has 
provided great insight into visual information processing. 
The current approach to investigate the neural basis of human vision is 
to relate psychophysical studies of humans to neurophysiological studies of 
animals. Psychophysics involves the 'objective' testing of visual performance 
and supplies information about the sensitivity and limitations of vision. Neuro-
physiology involves outlining the processing capacity of single neurons at 
different levels of the visual pathway and tells us about the neural organization 
and structure of the visual system. 
CS measurements conducted on patients with various neurological disorders 
have suggested that the spatial channels of vision can be affected differentially 
in a large variety of ways. 
The investigations in Parkinsonian patients have demonstrated that a selective 
loss of visual function can be associated with a certain pathology. A substantial 
proportion of patients with dopaminergic deficiency, from whatever cause, 
showed frequency-selective and orientation-specific CS losses (Chapter II). On 
the other hand, from the standpoint of normal vision, these findings may indicate 
that dopamine is a functional transmitter in the visual pathway. 
Another example of how our knowledge about the neural basis of human 
vision can benefit from results under pathological conditions has been dem-
onstrated by CS measurements in patients with cerebral infarctions. The 
observation that visual perception was distorted in a qualitatively different way 
according to the antero-posterior site of the lesion may indicate that neural 
mechanisms in different parts of the visual pathway are tuned to different 
spatial frequencies (Chapter III). 
The selective damage of some frequency-selective channels has also been 
demonstrated in patients with cerebral tumours. Even tumours without direct 
involvement of the visual pathway (papilloedema and hydrocephalus) showed 
frequency-selective CS losses (Chapter IV). 
Psychophysics can also have a role in translating the dysfunction which 
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characterizes the condition into a neurophysiologically meaningful code. Since 
in most cases neurophysiological investigation cannot be carried out on the 
diseased structure, psychophysics may represent the only quantitative link 
between the human condition and its neurophysiological investigation and 
simulation in animals. The results of CS measurements in patients with Benign 
Intracranial Hypertension (BIH) showed a close relationship between the 
presence of its characteristic visual symptoms ( obscurations and blurred vision) 
and abnormal CS function (Chapter V). 
The relationship between psychophysics and neurophysiology of disease can 
also have a number of useful secondary functions. It can contribute to early 
detection of disease and to more sensitive methods of monitoring the progress 
of a disease. This has been illustrated by the serial measurements in 11 patients 
with BIH. Progressive visual loss in longstanding papilloedema and improvement 
of visual function in subsiding papilloedema was demonstrated without any 
change in Snellen acuity or visual field charting. 
Clearly, we are at an interesting stage in the study of the psychophysical 
defects in neuro-ophthalmological disorders. We need to refine our stimulus 
on the basis of what has already been learned and proceed. 
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GENERAL SUMMARY 
In this thesis studies are described investigating contrast sensitivity (CS) 
function in normal subjects and in patients with various neurological disorders. 
Chapter I gives a review of neurophysiological concepts underlying human 
contrast sensitivity function. These developed from basic research conducted 
on the electrophysiology and psychophysics of animals and humans. It has 
been proposed that visual information is transmitted via parallel channels, each 
channel carrying a limited range of spatial frequencies. Visual disturbances 
can result from damage to some or all spatial frequency channels. Such abnormal 
visual function does not necessarily result in abnormal Snellen acuity. 
Part 2 of this Chapter deals with the methods of measurement of contrast 
sensitivity. 
In part 3 the results of contrast sensitivity (CS) measurements in 54 normal 
subjects are described. Although CS varies within age-decade subgroups, it is 
not affected by age. It is demonstrated that there is a great test-retest consistency. 
Chapter II is devoted to studies of CS on Parkinsonian patients. Although 
motor manifestations are the main sequelae of Parkinson's disease (PD), the 
disorder is probably more generalized, perhaps a generalized dopaminergic 
deficiency syndrome. In animals there are dopamine projections in parts of 
the peripheral visual system and dopamine-sensitive cells are also known to 
exist in the human retina. In the mesocortical pathway dopamine deficiency 
has been demonstrated in PD by positron emission tomography. In view of 
the assumed dopaminergic transmission in the visual system, CS measurements 
were used to analyse visual function in idiopathic and drug-induced Parkins-
onism. 
Part 1 describes CS measurements in 39 patients with PD, without levodopa 
therapy. Sixty-four per cent of the patients had CS loss in one or both eyes. 
Most had high frequency loss, intermediate frequency loss (notch loss), or 
both. The patients had normal subjective visual function, and the visual acuities 
were 7/10 or more. Abnormality ofCS was not related to severity ofthe disease 
or the first symptom. The occurrence of sensitivity loss at intermediate fre-
quencies in 16 of the 48 "affected" eyes may implicate cortical involvement, 
as spatial frequency selectivity is mainly attributed to cortical neurons and not 
or only to a less degree, to neurons of the retina and geniculate body. The 
results of this study are consistent with the concept that PD is a widespread 
transmitter deficiency syndrome. 
In part 2 changes in CS function after institution of levodopa substitution 
therapy are described in 10 PD patients. Before levodopa treatment, 16 of 20 
eyes showed abnormal CS function. Mter treatment only six of the 20 eyes 
still showed abnormalities, all high frequency loss. In the pretreatment group 
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a substantial proportion of the CS loss was restricted to a particular band of 
spatial frequencies. All these intermediate spatial frequency losses appeared 
reversible under levodopa treatment. The change of CS function after treatment 
suggests that dopamine is a functional transmitter in the visual pathway. 
Part 3 shows the results of a study investigating the effect of stimulus orientation 
on CS in 21 PD patients. Fifteen of these showed CS deficit in at least one 
eye. CS measuring for different orientations revealed that 17 of the 25 'affected' 
eyes showed orientation-selective deficits. The most frequent type of orientation-
selective loss, observed in 12 cases, was a notch defect, which preferentially 
affected the middle spatial frequencies. Because orientation-selective neurons 
are not found peripheral to the primary visual cortex in primates, the finding 
that 68 per cent of the 'affected' eyes showed orientation-selective deficits, 
indicates that the visual disturbances in PD are, at least in part, situated at 
the primary visual cortex. 
The effects of systemic administration of dopamine blockers on CS function 
in previously untreated patients were investigated in the study presented in 
part 4. CS determinations for vertical and horizontal orientations revealed CS 
loss in nine of the 10 patients with drug-induced Parkinsonism. There was 
a striking resemblance of the pattern of CS loss in drug-induced Parkinsonism 
to that in idiopathic PD. The most frequent type of deficit observed in 14 
eyes was also a notch loss, which preferentially affected the middle and low 
spatial frequencies. All spatial frequency-selective CS losses were stimulus 
orientation dependent. This curious parallel suggests that dopaminergic de-
ficiency, from whatever cause, has similar effects on visual function. 
Chapter III presents the results of CS measurements in patients with unilateral 
ischaemic lesions involving the posterior visual pathway. Ten of the 16 patients 
had at least one eye with CS deficit for vertical and/ or horizontal stimuli. Visual 
perception was distorted in a qualitatively different way according to the antero-
posterior site of the lesion. Patients with occipital or occipita-temporal lesions 
showed high spatial frequency-selective losses and patients with temporal and 
parietal lesions low frequency-selective losses. Neural mechanisms in the anterior 
part of the postchiasmal visual pathway seem selectively sensitive (tuned) to 
low spatial frequencies, while high frequency tuning might exist in the posterior 
part, at the level of, or central to the primary visual cortex. Stimulus orientation 
selectivity was observed in patients with lesions of the primary visual cortex 
as well as in patients with lesions anterior· to the striate cortex. Orientation 
selectivity is not confined to primary visual cortex neurons, but also exists in 
the posterior visual pathway prior to the striate cortex. 
Chapter IV describes the results of CS measurements in patients with cerebral 
tumours. Cerebral tumours may produce various visual symptoms and signs 
depending on the site of the tumour. In 18 of the 23 patients the tumour 
had directly or indirectly involved the visual pathway. CS function was abnormal 
in 27 of the 36 eyes (75%). There was no apparent correspondence of visual 
acuity or visual field loss to CS function. Intermediate spatial frequency loss 
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was obsenred in 18 of the 27 'affected' eyes, in three other eyes combined 
with other types of CS loss. Three patients with a tumour outside the visual 
pathway, and bilateral papilloedema as the only neuro-ophthalmological sign, 
showed notch losses in both eyes. Functional disruption or anatomical lesions 
of the visual pathway, from optic nenre to primary visual cortex, can selectively 
damage some frequency-selective channels, while others continue to function 
normally. 
Chapter V deals with CS function in patients with Benign Intracranial 
Hypertension (BIH). Spatial CS function, in 20 BIH patients, was abnormal 
in 16 of the 37 non-amblyopic eyes. Only four of these 16 eyes had also acuity 
loss, indicating that CS measurement is superior in detecting visual loss than 
Snellen acuity tests. Visual obscurations and blurred vision are the most frequent 
visual symptoms in BIH. In this study all 11 patients with these symptoms 
had abnormal CS functions. The clinical application of CS measurement in 
BIH for monitoring the progression or regression of the disease is illustrated 
by serial measurements in 11 patients. Progressive visual loss in longstanding 
papilloedema and improvement of visual function in subsiding papilloedema 
can occur without any change in Snellen acuity or visual field charting. 
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SAMENVATTING 
Dit proefschrift behelst een klinisch onderzoek over de visuele contrast 
gevoeligheid bij proefpersonen en patienten met verschillende neurologische 
aandoeningen. 
Hoofdstuk I geeft een kort overzicht van neurofysiologische begrippen die 
aan de contrast gevoeligheid functie ten grondslag liggen. Deze zijn gebaseerd 
op resultaten van elementair electrofysiologisch en psychofysisch onderzoek 
bij dier en mens. Er zijn aanwijzingen dat de visuele informatie wordt 
overgebracht via parallel lopende 'kanalen', waarbij elk kanaal een beperkt 
aantal spatiele frequenties bevat. Visuele stoornissen kunnen veroorzaakt 
worden door een beschadiging van enkele of aile spatiele frequentie kanalen. 
Een dergelijke visuele stoornis behoeft niet noodzakelijkerwijs te leiden tot 
verminderde gezichtsscherpte, zoals die wordt onderzocht met de Snellen kaart. 
In het tweede deel van hoofdstuk I wordt de methode om de contrast 
gevoeligheid te meten beschreven. 
In het derde deel worden de resultaten vermeld van de contrast gevoeligheid 
(CG) metingen bij 54 proefpersonen. Ofschoon de individuele CG binnen de 
subgroepen, verdeeld in leeftijd-decaden varieert, heeft de leeftijd geen invloed 
op de CG. De individuele test resultaten bleken in hoge mate reproduceerbaar. 
In hoofdstuk II worden de resultaten besproken van de CG bepalingen bij 
patienten met de ziekte van Parkinson en patienten met medicamenteus 
geinduceerd Parkinsonisme. De belangrijkste gevolgen van de ziekte van 
Parkinson worden waargenomen aan het motorische systeem. Er zijn echter 
aanwijzingen dat de "stoornis" meer gegeneraliseerd is, mogelijk is er sprake 
van een gegeneraliseerd dopaminerg deficientie syndroom. In onderdelen van 
het visuele systcem zijn bij verschillende diersoorten dopamine projecties 
aangetoond, terwijl ook bij de mens 'dopamine-gevoelige' cellen voorkomen 
in de retina. Met behulp van positron emissie tomografie is bij Parkinson 
patienten bovendien een dopamine deficientie waargenomen in de meso-
corticale banen. De veronderstelde dopaminerge transmissie was de beweeg-
reden om m.b.v. CG metingen het visuele systeem bij patienten met de ziekte 
van Parkinson en patienten met Parkinsonisme te analyseren. 
In het eerste gedeelte van hoofdstuk II worden de resultaten weergegeven 
van de CG metingen bij 39 patienten met de ziekte van Parkinson. Deze patienten 
werden niet behandeld met levodopa. Vierenzestig procent van de patienten 
hadden een CG verlies van een of beide ogen. Verminderde CG in het hoog 
frequente gebied en intermediair CG verlies ('notch loss'), of een combinatie 
van deze kwam het meest frequent voor. Het subjectieve gezichtsvermogen 
van de patienten was normaal en de gemeten Snellen visus was 7/10 of beter. 
Er bleek geen relatie te bestaan tussen de CG test resultaten en de ernst of 
het eerste symptoom van de ziekte. Omdat spatiele frequentie selectiviteit een 
eigenschap is die wordt toegeschreven aan corticale neuronen en niet, of in 
veel mindere mate, aan retina- of corpus geniculatum neuronen, zou het 
intermediaire gevoeligheidsverlies dat werd gevonden bij 16 van de 48 'aan-
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gedane' ogen er op kunnen wijzen dat de visuele cortex bij de ziekte betrokken 
is. De resultaten van deze studie zijn in overeenstemming met de opvatting 
dat de ziekte van Parkinson een wijd v.erspreid transmitter deficientie syndroom 
is. 
In het tweede gedeelte worden de veranderingen beschreven in de, CG curve 
bij 10 Parkinson patienten, na het instellen van levodopa substitutie therapie. 
Voor de behandeling hadden 16 van de 20 ogen een afwijkende CG curve. 
Na het instellen van de behandeling vertoonden zes van de 20 ogen nog een 
abnormale curve, terwijl bij deze behandelde patienten aileen afwijkingen in 
het hoog frequente gebied gevonden werden. Voor de levodopa therapie bleek 
bij een groot gedeelte van de patienten het gevoeligheidsverlies beperkt te zijn 
tot een band van spatiele frequenties. Al deze intermediaire CG dalingen bleken 
reversibel te zijn onder levodopa therapie. De verandering van de CG functie 
onder invloed van deze medicatie suggereert dat dopamine een functionele 
transmitter is in het visuele systeem. 
Het onderzoek in deel drie van dit hoofdstuk gaat na wat de invloed is 
van de orientatie van de stimulus op de CG bij 21 Parkinson patienten. Vijftien 
van de 21 patienten hadden een gevoeligheidsverlies aan tenminste een oog. 
Door de CG met verschillende stimulus orientaties te meten kon worden 
aangetoond dat 17 van de 25 'aangedane' ogen een orientatie-selectief CG verlies 
hadden. Het meest voorkomende type van orientatie-selectief verlies, dat werd 
waargenomen bij 12 ogen, was een 'notch defect', vooral optredend in het 
mid-frequente gebied. Het wordt verondersteld dat orientatie-selectieve neu-
ronen bij de primaten niet perifeer van de primaire visuele cortex voorkomen. 
Deze studie toont aan dat 68 procent van de 'aangedane' ogen een orientatie-
selectieve gevoeligheidsdaling heeft. Hieruit zou kunnen worden afgeleid dat 
de visuele stoomissen bij Parkinson patienten, tenminste gedeeltelijk, hun 
oorsprong hebben in de primaire visuele cortex. 
De effecten op de CG curve van medicamenten die een 'dopamine blok-
kerende' werking hebben, worden beschreven in deel 4 van dit hoofdstuk. CG 
metingen met verticale en horizontale stimuli, lieten een gevoeligheidsdaling 
zien bij negen van de 10 patienten met medicamenteus gei:nduceerd Parkinso-
nisme. Het patroon van CG verlies bij deze groep patienten geleek sterk op 
het patroon dat gevonden werd bij patienten met de idiopathische ziekte van 
Parkinson. Het meest frequent voorkomende type van CG verlies, bij 14 van 
de 20 ogen, was ook hier een 'notch defect'. Deze frequentie-intermediaire 
gevoeligheidsdalingen werden gevonden in de mid- en lage spatiele frequentie 
gebieden. Alle spatiele frequentie-selectieve CG dalingen waren stimulus-
orientatie afhankelijk. Deze opmerkelijke parallel suggereert dat dopamine 
deficientie, waar ook door veroorzaakt, een gelijkvormig effect heeft op de 
visuele functie. Al deze bevindingen duiden erop dat dopamine een functionele 
transmitter is in het visuele systeem. , 
Hoofdstuk III geeft de resultaten weer van CG metingen bij patienten met 
een eenzijdige ischaemische laesie van het visuele systeem, posterior van het 
corpus geniculatum laterale. Tien van de 16 patienten hadden tenminste een 
oog met een CG daling voor vertic ale en/ of horizontale stimuli. De voor-
achterwaartse lokalisatie van de laesie bleek bepalend voor het spatiele fre-
quentie gebied waar het CG verlies optrad. Patienten met een occipitale of 
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occipito-temporale laesie hadden frequentie-selectieve gevoeligheidsdalingen 
in het hoog frequente gebied en patienten met temporale en parietale laesies 
frequentie-selectieve CG dalingen in het laag frequente gebied. Neuronale 
mechanismen in het voorste gedeelte van het post-chiasmale visuele systeem 
lijken selectief gevoelig te zijn voor lage spatiele frequenties, terwijl het posterior 
gelegen gedeelte van het visuele systeem, t.h.v. de primaire visuele cortex en 
gebieden centraal daarvan, een selectiviteit voor hogere spatiele frequenties 
hebben. Selectiviteit van de stimulus orientatie werd zowel waargenomen bij 
laesies van de primaire visuele cortex als bij laesies v66r de area striata gelegen. 
Orientatie-selectiviteit is niet aileen een eigenschap van neuronen van de 
primaire visuele cortex, maar deze bestaat klaarblijkelijk ook in meer centraal 
gelegen gebieden van het post-chiasmale visuele systeem. 
Hoofdstuk IV beschrijft de resultaten van CG metingen bij patienten met 
hersentumoren. Afhankelijk van de lokalisatie van de tumor, kunnen verschil-
lende visuele verschijnselen optreden. Bij 18 van de 23 patienten was er sprake 
van een direct of indirect effect v:m de tumor op het visuele systeem. De CG 
functie was abnormaal bij 27 van de 36 ogen (75%). Er bleek geen duidelijke 
overeenkomst te bestaan tussen verminderde Snellen visus en gezichtsveld-
defecten en CG verlies. CG dalingen beperkt tot intermediaire spatiele fre-
quenties, werden bij 18 van de 27 'aangedane' ogen gevonden, bij drie andere 
gecombineerd met andere typen CG verlies. Drie patienten hadden een tumor 
buiten het visuele systeem gelegen, bij wie bilateraal papiloedeem het enige 
neuro-ophthalmologisch verschijnsel was. Aile zes ogen vertoonden een 'notch 
defect' bij CG onderzoek. Functionele en anatomische laesies van het visuele 
systeem, van nervus opticus tot en met area striata, kunnen een beschadiging 
veroorzaken van sommige frequentie-selectieve kanalen, terwijl andere normaal 
blijven functioneren. 
Hoofdstuk V is gewijd aan de CG functie bij patienten met Benigne 
Intracraniele Hypertensie (BIH). Bij de 20 BIH patienten werd een abnormale 
CG functie gevonden bij 16 van de 37 niet-amblyope ogen. Slechts vier van 
deze 16 ogen hadden ook een verminderde Snellen visus, waaruit zou kunnen 
worden afgeleid dat een CG meting gevoeliger is voor het ontdekken van visueel 
functie verlies i.v.t. een Snellen visus bepaling. Visuele obscuraties en wazig 
zien zij de twee meest voorkomende visuele symptom en bij BIH. Aile 11 patienten, 
die deze symptomen hadden, vertoonden abnormale CG curven. De klinische 
toepassing van CG meting bij BIH om progressie of regressie van de ziekte 
te constateren wordt gei:Ilustreerd aan de hand van opeenvolgende metingen 
bij 11 BIH patienten. Progressieve visuele stoomissen bij langdurig bestaand 
papiloedeem en verbetering van de visuele functie bij verdwijnend papiloedeem 
kunnen v66rkomen zonder enige verandering van de Snellen vis us of gezichts-
velden. 
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